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ABSTRACT 
 
 
Glycemic Load and Risk of Alzheimer’s Disease:  
 
The Cache County Study on Memory,  
 
Health, and Aging 
 
 
by 
 
 
Eun Young Choi, Master of Science 
 
Utah State University, 2008 
 
 
Major Professor: Dr. Ronald G. Munger 
Department: Nutrition and Food Science  
 
      
Carbohydrates are a major energy source for the human body and particularly 
glucose is the only energy source for the brain. Thus glucose metabolism is important to 
maintain normal brain function. Evidence showed insulin resistance and diabetes are 
associated with cognitive decline and a large amount of highly processed carbohydrate 
intake; in other words, a high glycemic load diet, which increases blood glucose faster 
and insulin demand, is associated with increased risk of insulin resistance and diabetes.   
Based on this premise, the hypothesis that a high glycemic load (GL) diet 
increases the risk of incident Alzheimer’s disease (AD) was examined among Cache 
County elderly people in Northern Utah. At the baseline survey, 3,831 participants 65 
years of age or older completed a food frequency questionnaire (FFQ) and cognitive 
screening. Observation time to collect the data for incident AD was approximately 10 
years. Incident AD was determined by final consensus conference after multi-steps of 
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screening. GL was calculated as the product of carbohydrate intake and glycemic index 
(GI) and adjusted for energy intake. FFQs from diabetics were considered to be invalid 
to assess dietary carbohydrates intake and excluded. The analysis was examined 
separately by gender.  
The Cox proportional hazard regression model in survival analysis was used to 
relate GL to incident AD using a time variable with age of AD onset. There was no 
association in men but a negative association in women in the unadjusted model. 
Evidence of confounding by total kcal was apparent in women, particularly in the lowest 
GL group, which had the highest total kcal mean intake. Finally no association between 
GL and AD was found after adjustment for education, myocardial infarction (MI), stroke, 
Body Mass Index (BMI), physical activity, smoking, alcohol use, APOE ε-4 alleles, 
multi-vitamins use, total kcal, and controlling interaction between GL and total kcal.  
The low GL group had unique characteristics in lifestyle factors, macro-nutrients 
intake, and pattern of food use. The inverse relationship between GL and total kcal may 
partly be explained by lifestyle factors, particularly alcohol intake. The characteristics of 
low GL group, current smokers, alcohol users, and their relationship and interaction 
between total kcal and risk of AD should be explored further.  
(99 pages) 
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INTRODUCTION 
 
 
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that affects 
millions in the aging population.  The prevalence of AD is estimated to increase three-
fold in the United States and four-fold worldwide from current affected number by 2050 
(1, 2). AD is the fifth leading cause of death in Americans age sixty five and older in 
2005 and has appeared as the third leading cost of care in medical condition in the United 
States (1, 3). Sharply increasing number of AD patients indicates a growing socio-
economic burden due to increasing number of functional dependence of aging 
populations, thus emphasis in strategies and efforts intended to maintain functional and 
cognitive health may be particularly important to prevent occurrences of dementia and 
AD. 
The Cache County Study on Memory, Health, and Aging, established in 1994, is a 
prospective cohort study of prevalence and incidence of dementia and AD among 5,092 
Cache County elderly people in Utah (3). The study has contributed to deepening and 
broadening the knowledge of AD in depth and breadth during four waves and three 
follow-up assessments. Dietary factors such as anti-oxidant vitamins from supplements 
and dietary intake and fruits and vegetables intake have been examined as modifiable risk 
factors that may reduce risk of AD in the study.     
Dietary carbohydrate intake affects the brain energy metabolism and may be an 
important role in the pathology of AD. Substantial number of prospective cohort studies, 
two cross sectional studies, and one meta-analysis of clinical trials found the association 
between diabetes (4-8), insulin resistance (9-12), hyperinsulinemia (13-17), and increased 
risk of cognitive decline and AD. Evidences provided from clinical trials, large 
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prospective cohort studies, and population-based cross-sectional studies showed the 
association between high dietary intake pattern of carbohydrates that are rapidly absorbed 
from the gastrointestinal tract in term of glycemic index (GI) and glycemic load (GL) and  
increased risk of insulin resistance and type II diabetes (18-28). Based on these premises, 
the hypothesis that high glycemic load diet may increase the risk of AD is proposed. 
However, there was little study on this hypothesis and no association between GL and the 
risk of AD was found in a longitudinal cohort study (29). 
Although supporting evidence from population studies are scant, the intent of this 
study is to examine the association between higher glycemic load and the risk of AD 
based on the following associations: association between glycemic index and glycemic 
load and insulin resistance and type II diabetes, and association between insulin 
resistance and type II diabetes and Alzheimer’s disease. 
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REVIEW OF LITERATURE 
 
 
Alzheimer’s disease 
Alzheimer’s disease (AD) is not a normal part of aging but a progressive 
neurodegenerative brain disease in the elderly population (30). It is characterized by 
neuritic plaques from abnormally aggregated beta-amyloid peptide and intracellular 
neurofibrillary tangles (NFTs) from paired helical filaments of hyperphosphorylated 
microtubule-associated tau protein in the brain (30, 31). In 1907, Dr. Alois Alzheimer, a 
German neuropathlogist and psychiatrist, was the first to report findings of senile plaques 
and neurofibrillary tangles (31).  
AD is the most common form of dementia accounting for 50 to 70 percent of the 
total dementia cases, begining with early signs including memory loss and subtle 
behavior changes (30). The symptoms of AD are not limited to memory loss and other 
cognitive deficits but extend to a wide range of challenges, such as impaired activities of 
daily life, depression, behavioral disturbances (30). Thus caring for AD patients becomes 
a physical, psychological, emotional, and financial burden on the family and caregivers 
along with the progression of the disease. 
The mortality of AD had shown an increasing trend, particularly from 2000 to 2005, 
deaths from Alzheimer’s disease increased by 44.7 percent, while the number one cause 
of death, heart disease, decreased by 8.6 percent and percentages in other cause of death, 
such as breast cancer, prostate cancer, and stroke tended to decrease (1). Approximately 
5.2 million Americans were estimated to be affected by AD in 2008 (1). By 2050, the 
number of people of age 65 and over with AD will increase by almost three-fold ranging 
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from 11 million to 16 million if effective prevention or treatment are not available for the 
disease (1). The growing prevalence of AD along with increased life expectancy has 
appeared not only in the United States but also worldwide (1). Brookmeyer et al. 
estimated that the worldwide prevalence of AD was 26.6 million in 2006 and this number 
would increase fourfold, to 106.8 million in 2050 (about 1 in 85 persons) (32). 
In the United States, direct and indirect costs of AD patients care, including 
Medicare, Medicaid, and business of caregiving, are projected to be more than $148 
billion annually (1). The worldwide cost for dementia care including AD is estimated to $ 
315 billion annually (33). This projected economic burden on medical cost along with 
substantially increasing prevalence of AD, indicates its impact on public health and 
imperative socioeconomic burden in near future. Therefore, it is crucial to study the 
pathology of AD and to find potential modifiable risk factors to reduce incidence of AD 
or to prevent cognitive impairment. 
The risk of cognitive decline and AD, like other common chronic conditions, is 
influenced by multiple clustering factors, such as age over 65 years, genetics (APOE ε-4 
gene), chronic condition of insulin resistance, type II diabetes, inflammation, oxidative 
stress, dietary factors, environmental factors (exposure to the exogenous substances, such 
as metals and pesticides), lifestyles, education levels, gender, and head trauma (34).  
Dietary factors are among modifiable risk factors and may play an important role in 
prevention or precipitation of cognitive decline and AD. Dietary factors, such as calorie 
restriction, homocysteine-related B-vitamins (vitamin B6, B12, folate), fatty acids 
including cholesterol, polyunsaturated fatty acids (PUFA), omega-3 fatty acids, 
docosahexaenoic acid (DHA) from fish linked to APOE ε-4 alleles, antioxidant nutrients 
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related to oxidative stress, flavonoids, and alcohol have been studied to find a way to 
reduce the risks of AD in prospective studies and clinical trials (34-38), but reports were 
inconsistent (36, 37). 
The application of nutrition to the epidemiologic study, especially related to 
chronic diseases, is indeed complex because dietary components are highly interrelated to 
each other and people eat a mixed diet, not isolated foods or individual nutrients (39, 40).  
Thus, examining dietary patterns or food groups, which includes both macro- and micro-
nutrients components, may capture the complexity of diet and be relevant in exploring the 
association between dietary factors and chronic diseases. The data from the Cache 
County on Memory, Health and Aging study by Wengreen et al. showed an example 
focusing on the relation between food groups and cognitive decline and dementia in 
which higher intakes of fruits and vegetables and consumption of fish at least once a 
week were associated with reduced risk of cognitive decline or dementia, particularly 
among ApoE4 non-carriers (41).   
Mediterranean diet (MeDi) has received growing attention because of ecological 
and observational evidence of reduced risk for cardiovascular disease (CVD), certain 
forms of cancer, and overall mortality (25, 39). Recently the Washington Heights-Inwood 
Columbia Aging Project (WHICAP) study among 2258 community-based non-demented 
individuals, mean age of 77.2 years, by Scarmeas et al. showed that higher adherence to 
the MeDi is associated with reduced risk for AD (39). The characteristics of the MeDi, 
such as high intake of vegetables, legumes, fruits and cereals, olive oil, a moderate-high 
intake of fish, a low to moderate intake of dairy foods, a low intake of meat and poultry, 
and a regular but moderate amount of wine generally during the meals, seem to represent 
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many potentially beneficial dietary components for AD (35, 39).   
But there are not many studies regarding the effect of dietary patterns on the risk of 
AD, thus with this perspective, diets low in GI and GL, which are characterized by more 
whole-grain foods, fruits and vegetables with high in fiber, vitamins, and minerals, may 
be good candidates dietary patterns to look into the reduced risk of AD.  
 
Type II diabetes and Alzheimer’s disease 
Type II diabetes is the product of progressive abnormalities: insulin resistance, 
hyperinsulinemia, then pancreatic exhaustion as a result of the increased demand for 
insulin in early stage and is characterized by hyperglycemia at an advanced stage (27, 42-
44). Type II diabetes mellitus is a pandemic public health problem; the global prevalence 
of diabetes in 2000 was estimated at 171 million; by the year 2030, almost twofold of that, 
about 366 million people, will be afflicted with diabetes (45, 46). The U.S. Centers of 
Disease Control and Prevention estimated that total prevalence of diabetes in the United 
States in 2005 was 20.8 million (7% of the population); 6.2 million people among 
diabetes were undiagnosed and about 10 million, half of these persons, are aged 60 years 
or older (47). It is indeed surprising that 6.2 million people, about one third of diabetes, 
are undiagnosed. Diabetes is the sixth-leading cause of death and it is the most common 
metabolic disorder that has been associated with various adverse health effects including 
heart failure, stroke, kidney failure, and cognitive impairment and AD (48, 49).  
Criteria for the diagnosis of diabetes in non-pregnant adults are shown in Table 1 
from the American Diabetes Association (ADA) (50). There are three ways to diagnose 
diabetes, and each must be confirmed on a subsequent day unless clear symptoms of 
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hyperglycemia are present (50). Although the 75g oral glucose tolerance test (OGTT) is 
more sensitive than fasting plasma glucose (FPG) to diagnose diabetes, the FPG test is 
preferred in practice because it is easy to use, costs less, and is more acceptable to 
patients than the OGTT test (50).  
By ADA definition, impaired fasting glucose ( IFG=fast plasma glucose 100 mg/dl 
(5.6 mmol/l) to 125 mg/dl (6.9 mmol/l)) and impaired glucose tolerance ( IGT= 2-h 
plasma glucose 140 mg/dl (7.8 mmol/l) to 199 mg/dl (11.0 mmol/l))have been officially 
termed “pre-diabetes” and both categories, IFG and IGT, are risk factors for future 
diabetes and cardiovascular disease (50). 
Type II diabetes has been associated with cognitive decline and AD in their  
 
pathogenesis and disease progress linked to underlying mechanism of insulin resistance  
 
(43, 49). First of all, Stewart et al. showed that type II diabetes elevated the risk of both  
 
vascular dementia and AD (51). 
 
 
Table 1. Criteria for the diagnosis of diabetes (cited from ADA)  
* Symptoms of diabetes and a casual plasma glucose ≥ 200 mg/dl (11.1 mmol/l) 
  Casual is defined as any time of day without regard to time since last meal.  
  The classic symptoms of diabetes include polyuria, polydipsia,    
  and unexplained weight loss.     
* FPG ≥126 mg/dl (7.0 mmol/L) 
   
  
  Fasting is defined as no caloric intake for at least 8 hours   
* 2-hour plasma glucose ≥ 200 mg/dl (11.1 mmol/L) during an OGTT   
  
OGTT test: glucose load containing 75 g anhydrous glucose dissolved in 
water 
FPG, fasting plasma glucose; OGTT, oral glucose tolerance test  
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In the early population-based prospective cohort study (the Rotterdam study) and 
later study in which 6,370 elderly people participated for 2.1 years, Ott et al. found that 
people with diabetes had almost a doubled risk of dementia and AD (relative risks with 
proportional hazard regression; both RR = 1.9) and more importantly patients receiving 
insulin treatment were at highest risk of dementia (RR = 4.3) (6, 52).   
The Honolulu-Asia Aging Study conducted by Peila et al. with a population-based 
cohort of 2,574 Japanese-American men, found that diabetes was associated with total 
dementia, AD, and vascular dementia and the association between diabetes and AD was 
particularly strong among APOEe4 carriers (7). Another cohort study, in which 1,789 
Latinos aged 60 and older participated during 1998-1999, showed that risk of dementia 
was nearly eight times higher in people with type II diabetes and stroke (53). The largest 
cohort, Nurses’ Health Study, in which 18,999 women aged 70-81 years participated for 
2 years, reported women with type II diabetes had increased odds of poor cognitive 
function and substantial cognitive decline (54). Arvanitakis et al. also found evidence 
among 824 older Catholic nuns, priests, and brothers (55). 
However, the Canadian Study of Health and Aging by Mcknight et al. found 
contradicting result that no significant association existed between diabetes and AD, but 
significant with vascular impairment (56). Yamada et al. also had no significant finding in 
the Hiroshima Adult Health Study (57). In a historical prospective cohort study of 
Japanese-American men (n =3774) who were examined at ages 45 to 68 (1965 through 
1968) and again at ages 71 to 93, (1991 through 1993) there has no relation of a 15-year 
or 25-year history of diabetes to AD (58), but a later study with the same sample 
mentioned above (the Honolulu-Asia Aging Study) showed patients with type II diabetes 
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had a significant association with AD (7). 
Similarly, the early population-based study by Hassing et al. (59) found no 
association in AD with diabetes, but later longitudinal population-based study found that 
type II diabetes was associated with accelerated cognitive decline (60). Luchsinger et al. 
also produced conflicting results that had no significant diabetes-AD association among 
Blacks and Hispanics in their earlier study (5), but later studies showed that diabetes and 
current smoking were the strongest risk factors (4). The strong association between 
hyperinsulinemia and risk of AD among multiethnic elderly in Northern Manhattan was 
also found (13). Recently, Luchsinger et al. reported evidence of association between 
diabetes and higher risk of mild cognitive impairment (MCI) among same group, 
Northern Manhattan 1772 elderly people (61). Finally, in the Cache County Study on 
Memory, Health, and Aging, Charoonruk et al. found association of AD and type II 
diabetes in men (62). 
To conclude, most longitudinal and population based cohort studies or cross-
sectional studies have shown an increased risk of AD associated with diabetes and insulin 
resistance (hyperinsulinemia) even though some studies showed conflicting results.  
Furthermore, in several study groups, earlier findings weren’t significant, but later 
follow-ups showed significant results. Therefore, a strong body of studies supports a 
notion that type II diabetes may increase risk of AD. However, special attention may be 
needed in large population studies because considerable large proportion of type II 
diabetes were undiagnosed due to dependence on self-report or medical record for the 
diagnosis of diabetes (63). Also, increasing interest on pre-diabetes stage, which is 
characterized by insulin resistance and hyperinsulinemia, has produced some evidence of 
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possibility that insulin resistance may independently associated with AD risk (63).  
 
Insulin resistance and Alzheimer’s disease 
 
Insulin is a polypeptide consisting of alpha(α) and beta (ß) chain of 21 and 30 
amino acids and is linked through a pair of disulfide bonds (64). It is synthesized from 
the ß cells in the pancreas by cleavage of a C-terminal 23-amino-acid sequence of porcine 
proinsulin, thus it is produced with C peptide which is its by-product and often used as a 
measure of insulin production (64). The half-life of insulin is about 5 minutes and it is 
normally degraded in the liver, kidney and muscles by insulin degrading enzyme (IDE), a 
thiol methalloprotease (42, 64). 
Insulin is the only hormone that directly lowers blood glucose levels and plays the 
dominant role in the control of carbohydrate metabolism and also regulates fat and 
protein metabolism in many peripheral target tissues, such as hepatic cells, muscle cells, 
and adipose cells (64). For example, as the most important actions of insulin, insulin not 
only enhances the uptake of glucose in cells, where it is metabolized and stored as 
glycogen in the liver, but also stimulates protein synthesis in muscles as well as lipid 
synthesis in adiposities (64). Thus lack of insulin results in reversing action including 
lipolysis, ketogenesis, proteolysis due to unavailability of glucose and, ultimately, death 
(64).  If excess insulin is prolonged, it may result in hypoglycemia with consequent 
brain failure and again, finally, death (64). 
Other important actions of insulin are the effect on normal growth process and 
promotion of the full anabolic effect of growth hormone (64). Insulin is required for the 
action of growth hormone (GH) through its action on glucose uptake by muscle, and 
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provides the energy substrates necessary for protein synthesis and also its direct action on 
amino acid transport into the cells as well as RNA synthesis (64). For this reason, 
children with diabetes may experience dwarfism because insulin has an important role for 
the full anabolic effect of GH mainly in protein synthesis, and possibly due to the 
structural similarity of insulin, insulin-like-growth hormone-I (IGF-I), and their receptors 
(64). 
Another important action of insulin is to maintain potassium (K+) homeostasis by 
stimulating K+ uptake by cells, thus hyperinsulinemia may cause hypokalemia (potassium 
level less than 3.5 mEq/L) (64). The effect on insulin in the brain is less well defined 
compared with the effects on peripheral tissues. Historically, the brain has been described 
as an insulin-insensitive tissue; however, recent views on insulin in the brain suggested 
that insulin has important roles in the central nervous system (CNS). Craft et al. and 
Gerozissis described that peripheral insulin from the pancreatic beta cells can be 
transported into (CNS) both via across blood-brain barrier (BBB) by saturable, insulin 
receptor-mediated transport process and the cerebrospinal fluid (CSF) reached through 
circumventricular regions which is deficient in BBB (63, 65, 66). Saturability of glucose 
transport through the BBB was discovered by Banks et al. who explained the nonlinear 
relationship between the concentrations of human insulin in brain and blood, so insulin 
enters the brain by a saturable transport system (67). There is a hypothesis of biosynthesis 
of insulin in the brain from some studies (66, 68), but it is still inconclusive (63).  
Raising of the peripheral insulin concentration increases insulin concentration in brain 
and CSF, while chronic periphery hyperinsulinaemia down-regulates BBB insulin 
receptors thereby reducing insulin transport into the brain resulting in brain-insulin 
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deficiency (12, 63, 69)  
Insulin receptors (IR) are highly concentrated in several specific brain regions 
including the choroid plexus, olfactory bulb, piryform cortex, amygdaloid nucleus, 
hippocampus, hypothalamic nucleus, and cerebellar cortex that control fundamental 
behaviors such as food intake, reproduction, and cognition (42, 63, 66, 70).  
Glucose transport (GLUT) is mediated by 13 members of GLUTs family and 
expressed in specific cells and tissues; GLUT 1, 2, and 3 have been known to be not 
regulated by insulin, but GLUT 4 and 8 are insulin-sensitive transporters which increase 
glucose uptake 10- to 40-fold within minutes by translocation into membrane through 
insulin signaling cascade (42). GLUTs in CNS are mediated by mainly GLUT 1, 3, 4 and 
8; GLUT 1 and 3 are widespread in the brain; but insulin-sensitive GLUT 4 and 8 are 
selectively distributed in the brain, such as in the hippocampus and hypothalamus, 
indicating the effect of insulin in selective brain regions supporting memory (42, 71, 72).  
Craft has studied brain aging and described the role of insulin in the brain in her 
review paper which reported that insulin enhances memory with optimal plasma insulin 
levels of 10-20 µU/ml and sufficient glucose (69). This notion is supported by both 
animal (intracerebroventricular administration of insulin in rodents) and human 
(intravenous and intranasal insulin administration) studies which memory is facilitated by 
administration of insulin (11, 73). Insulin-modulated glucose utilization affects levels of 
neurotransmitters, such as acetylcholine and noreepiniphrine, that play important roles in 
cognition and long-term potentiation (LTP) of memory (12, 66, 69). Insulin also promotes 
rapid delivery of N-methyl-D-aspartate receptors to the cell membrane by exocytosis to 
modulate membrane potentials and neuronal firing/LTP in hippocampus (74, 75).  
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Gerozissis described insulin as a neuromodulator involved in neurotransmitter 
release and also as a regulator for food intake behavior and energy homeostasis related to 
body weight in hypothalamus (66, 76). Zhao examined the role of insulin and insulin 
receptor in learning and memory through molecular mechanism associated with cognitive 
function and aging (68). Insulin and insulin receptor modify neurotransmitter release 
processes at various types of presynaptic terminals and modulate the activities of both 
excitatory and inhibitory postsynaptic receptors (68). They also explained molecular 
mechanism of insulin and insulin receptor activities in the brain that insulin and insulin 
receptors participate in regulation of learning and memory through activation of specific 
pathways such as shc, Grb-r/SOS, Ras/Raf, MEK/MAP kinases, IRS1, PI3 kinase, and 
protein kinase C in the formation of long-term memory formation (68).  
Another role of insulin and IGF-1, which has similar molecular structures, in Aß 
clearance is that insulin increases Aß secretion by trafficking intracellular Aß from the 
Golgi to the plasma membrane and then IGF-1 enhances the transport of Aß carrier 
proteins (albumin and transthyretin) into the brain (77, 78).  
Therefore, peripheral insulin hormone has an important role in blood glucose 
homeostasis, the regulation of macronutrient metabolism, normal growth and 
development, and potassium (K+) homeostasis. In the brain, insulin is involved in 
memory, cognitive process with selective distribution of insulin, its receptors, and 
transporters, energy balance, and food intake behavior (12, 71, 75). Furthermore, insulin 
has an important role in Aß metabolism that increases Aß secretion and decreases the 
intracellular levels of Aß via intracellular trafficking mechanism (78). 
Insulin resistance is a diminished ability of cells to respond to the action of insulin 
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in transporting glucose from the bloodstream into muscle and other tissues and is a pre-
diabetes condition that appeared in 41 million people ages 40 – 74 (about 40% of US 
adult) in 2000 data from the U.S. Department of Health and Human Services (79).  
Reaven described “the insulin resistance syndrome” with a broad range of physiological 
abnormality rooted to insulin resistance as listed in Table 2 (80).  
From a molecular perspective, mechanism of insulin resistance can be divided into 
three categories; receptor, pre-receptor, and post-receptor insulin resistance (64). The 
majority of insulin resistance can be explained by the mechanism of the post-receptor 
insulin resistance due to the failure of signaling of insulin’s action by some intracellular 
effectors (64). Petersen et al. proposed a plausible mechanism of this post-receptor 
insulin resistance via the defects in insulin-stimulated muscle glycogen synthesis and 
increased intracellular lipid accumulation in muscle and liver tissue (48). 
Their mechanism is that increasing plasma fatty acid levels raises intracellular lipid 
metabolites, such as fatty acyl CoAs and diacylglycerol, which in turn activate protein 
kinase C (PKC), thus leading to defects in insulin signaling through phosphorylation of 
insulin receptor substrate (IRS)-1 (48). 
Blunted insulin-stimulated IRS-1 tyrosine phosphorylation by increasing PKC 
activity reduces phosphatidylinositol (PI) 3-kinase activity, which plays an essential role 
in insulin-stimulated glucose transport activity (GLUT 4), thereby resulting in reduced 
insulin-stimulated muscle-glycogen synthesis and increased plasma blood glucose levels 
(48). Thus increased intracellular lipid metabolites trigger the insulin resistance through 
the mechanism described above and this intracellular fat-induced insulin resistance 
mechanism is especially important.   
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Table 2. Abnormalities related to insulin resistance  
and hyperinsulinemia (cited from Reaven (80))  
* Some degree of glucose intolerance    
  Impaired fasting glucose     
  Impaired glucose tolerance    
* Dyslipidemia      
  ↑ Triglycerides     
  ↓ HDL-C      
  ↓ LDL-particle diameter (small, dense LDL particles) 
  ↑ Postprandial accumulation of triglyceride-rich lipoproteins 
* Endothelial dysfunction     
  ↑ Mononuclear cell adhesion    
  ↑ Plasma concentration of cellular adhesion molecules 
  ↑ Plasma concentration of asymmetric dimethylarginine 
  ↓ Endothelial-dependent vasodilatation     
* Procoagulant factors      
  ↑ Plasminogen activator inhibitor-1    
  ↑ Fibrinogen       
* Hemodynamic changes      
  ↑ Sympathetic nervous system activity    
  ↑ Renal sodium retention      
* Markers of inflammation      
  ↑ C-reactive protein, white blood cell count, etc.   
* Abnormal uric acid metabolism     
  ↑ Plasma uric acid concentration    
  ↓ Renal uric acid clearance     
* Increased testosterone secretion (ovary)     
* Sleep-disordered breathing      
HDL-C, high-density lipoprotein cholesterol; LDL, low-density lipoprotein. 
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Morino and Petersen et al. linked this intracellular fat-induced insulin resistance 
mechanism to mitochondrial dysfunction through magnetic resonance spectroscopy 
studies in healthy lean elderly subjects and healthy lean insulin-resistant offspring of 
parents with type II diabetes (45). They hypothesized that reduced mitochondrial function 
may predispose these individuals to intramyocellular lipid accumulation and insulin 
resistance (45). They assessed mitochondrial oxidative phosphorylation activity in the 
healthy lean elderly people and observed about 40% reduction in rates of this activity 
which is associated with increased intramyocellular and intrahepatic lipid content (45).  
For the Insulin-resistance offspring of patients with type II diabetes, their inherited 
condition causes a reduction in mitochondrial content in skeletal muscle by 38%, which 
in turn reduced rates of mitochondrial oxidative phosphorylation predisposing them to 
intramyocellular lipid accumulation by about 80% increase in its lipid content (45). 
In conclusion, molecular mechanisms in peripheral insulin resistance underscore 
the role of intracellular content of lipid in liver and skeletal muscle rather than absolute 
quantity of body fat. Obviously, insulin resistance occurs often in obese people because 
excess of caloric intake leads to fat accumulation not only in adipocytes, but also in 
muscle and liver cells. It also may occur in healthy and lean elderly people who acquired 
age-associated decline in mitochondrial function or inherited insulin-resistant offspring of 
parents with type II diabetes who have inherited reduction in mitochondrial density via 
mitochondrial dysfunction mechanism (45, 48). 
Petersen et al. provided evidence supporting the hypothesis described above as 
skeletal muscle insulin resistance mechanism from their recent human study (81). They 
reported the pattern of energy distribution derived from two high-carbohydrate meals in 
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young, lean, insulin-resistant individuals compared with young, lean, insulin-sensitive 
individuals (81). Their finding was that net muscle glycogen synthesis was reduced by 
about 60% in young, lean, insulin-resistant subjects compared to controls; on the contrary, 
hepatic de novo lipogenesis and hepatic triglyceride synthesis were both increased by 
greater than two fold in the insulin-resistant subjects, consequently resulting in increased 
plasma triglyceride concentration by 60% and decreased plasma high-density lipoprotein 
(HDL) concentration by 20% (81). The result indicates that insulin resistance in skeletal 
muscle can promote atherogenic dyslipidimia by changing the pattern of ingested 
carbohydrate away from skeletal muscle glycogen synthesis into hepatic de novo 
lipogenesis (81). 
Insulin resistance has a well known role in the metabolic syndrome, also known as 
the insulin resistance syndrome or syndrome X, which is a cluster of symptoms that 
include central obesity (men: waist circumference > 40 inches, women: waist 
circumference> 35nches), hyperglycemia (fasting glucose ≥ 110, < 126 mg/dl) , 
hypertension (blood pressure ≥ 130/80 mm Hg), dyslipidaemia (triglycerides ≥ 150 
mg/dl) , and low-HDL level (men < 40 mg/dl, women < 50 mg/dl) (80). The metabolic 
syndrome is estimated to affect more than 50 million Americans and approximately half 
of all Americans are predisposed to it (81). This cluster of metabolic anormalities have 
been linked to an increase in the risk of chronic diseases including CVD, CHD, type II 
diabetes, and AD. 
Watson and Craft et al. have intensively studied the role of insulin resistance 
particularly in the pathogenesis of AD. They explained that in the periphery, the most 
direct effects of insulin resistance are compensatory hyperinsulinemia and hyperglycemia 
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whereas in the CNS, insulin resistance may alter glucose metabolism in selective brain 
regions, as there is a unique distribution of insulin receptors and insulin-sensitive GLUTs 
in the hippocampus and adjoining medial temporal cortex (12, 42, 71, 72). Craft 
emphasized an important consequence of insulin resistance syndrome and reduced insulin 
transport into the brain, which causes brain insulin deficiency (12). Finally this 
insufficient insulin concentration in the brain compromises beneficial roles of insulin in 
CNS, thereby increases the risk of age-related memory impairment and AD (12). Other 
studies from Craft et al. have provided evidence for the association between insulin 
resistance and risk of cognitive impairment and AD. At first, in their 18 months 
longitudinal controlled clinical trial, they examined the effect of hyperglycemia on 
hormone levels, metabolite levels, and memory performance in 22 subjects with very 
mild and mild probable dementia of the Alzheimer type (DAT) and in 12 normal elderly 
adults (82). Subjects were tested in 3 plasma glucose conditions (fasting baseline, 175 
mg/dl, and 225 mg/dl) at initial and 18-month follow-up sessions. For the initial session, 
adults with very mild DAT showed memory facilitation and elevations in plasma insulin 
in the 225-mg/dl glucose condition relative to baseline, and then at follow-up, very mild 
DAT patients whose dementia had progressed showed significant decreases in insulin and 
hyperglycemic memory facilitation (82). This finding suggested that glucoregulatory 
abnormalities may contribute to the pathophysiology of DAT (82). 
   The following study explored whether memory improvement is due to a secondary 
elevation in plasma insulin levels, independent of hyperglycemia (83). They found that 
raising plasma insulin through intravenous infusion while keeping plasma glucose at a 
fasting baseline level produced striking memory enhancement for patients with DAT (83).  
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This finding proposed that neuroendocrine factors (insulin, insulin receptors, and insulin-
mediate glucose utilization) play an important role in the pathophysiology of DAT (83). 
Their continued clinical trial examined the effects of hyperinsulinemia acutely in 
older adults and in patients with AD using a hyperisulinemic-euglycemic clam. They 
found that normal older adults had a memory facilitation in plasma insulin levels of 10-20 
µU/ml (optimal levels in normal physiological condition) with low-doses of insulin 
administration, while AD patients with insulin resistance needed higher insulin doses 
achieving levels of 60-85 µU/ml to facilitate memory (84). They also found interesting 
results in the subgroup of AD patients with insulin resistance came from mainly non-
APOE ε-4 carriers indicating that insulin resistance may play an important role in 
pathogenesis of AD and may independently associated with increased risk of AD (84). 
Another clinical trial by Craft et al. with insulin treatment in 16 healthy older 
adults (mean age 68.7 years) examined insulin effects on CSF Aß42 levels (85). The 
result was that insulin infusion facilitated memory, however it increased CSF Aß42 levels 
particularly in older subjects and such memory facilitation was attenuated in the subjects 
with the greatest increase in CSF Aß42 levels (85). This study is consistent with role of 
insulin on Aß metabolism which increases CSF Aß levels by facilitating intracellular Aß 
trafficking to the membrane suggested by Gasparini et al. and implicating abnormal 
insulin metabolism in the pathophysiology of AD. 
Fishel and the Craft laboratory studied the effects of peripheral hyperinsulinemia 
on inflammation in the CNS through a similar experimental design with previous Aß and 
hyperinsulinemia study (86). Sixteen healthy older adults (mean age 68.2 years) received 
insulin infusion achieving plasma typical insulin resistance levels (>20 uU/mL) for 105 
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minutes and measured both plasma and CSF levels of inflammatory markers, cytokines 
(IL-1ß, IL-6, TNF-α, and F2-isoprostane (CSF only)) and Aß42. The result was that 
insulin increased CSF levels of F2-isoprostane and cytokines (both P<.01), as well as 
plasma and CSF levels of Abeta42 (both P<.05). These synchronous hyperinsulinemia-
induced increases in Aß42 and inflammation markers in the CNS may increase the risk of 
AD (86). 
Craft et al. proposed a model that their main hypothesis, in which insulin resistance 
and hyperinsulinemia contribute to the pathogenesis of AD, was linked to obesity through 
free fatty acids (FFAs) (87). Their mechanism is that peripheral insulin resistance and 
hyperinsulinemia increase peripheral FFA levels, which in turn elevate inflammatory 
agents in both periphery and CNS, reduce activity of insulin degrading enzyme, 
consequently inhibit peripheral Aß uptake and clearance, thereby increasing plasma Aß 
levels and elevate Aß transport into the brain (12, 87). This chain of effects is exacerbated 
by age and obesity (12, 87). Their cumulated experimental studies, based on the 
association between insulin resistance and AD, seemed to be integrated into this model. 
Craft pointed out the possibility that insulin resistance independent of diabetes or 
APOE ε-4 gene may increase the risk of AD (63) and population-based cross-sectional 
studies have provided evidence for this association.    
Kalmijn et al. from the Netherlands studied the cross-sectional association of 
cognitive function with hyperinsulinemia, impaired glucose tolerance (IGT), and diabetes 
in 462 men aged 69 to 89 years (88). They found that diabetes as well as non-diabetic 
subjects with IGT and hyperinsulinemia had impaired cognitive function as measured by 
the Mini-Mental State Examination (MMSE) (88). Another cross-sectional study of 980 
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people aged 69 to 78 (349 men, 631 women) from eastern Finland by Kuusisto et al. 
measured the insulin resistance syndrome and diagnosis of AD and found that in 532 non-
diabetic subjects without the APOE ε-4 allele, hyperinsulinemia was associated with an 
increased risk for Alzheimer's disease (prevalence of disease 7.5% v 1.4% in 
normoinsulinemic subjects, P = 0.0004) whereas in the 228 with the APOEe4, 
hyperinsulinemia had no effect on the risk of disease (7.0% v 7.1%, respectively) (17).  
This study suggested that insulin resistance syndrome is associated with Alzheimer's 
disease independently of APOEε-4 phenotype (17). Furthermore, a recent population-
based cohort study conducted by Luchsinger et al explored the association between 
hyperinsulinemia and risk of AD (13). 683 elderly people without dementia from 
northern Manhattan were followed-up for 3.7 years and the result was that the risk of AD 
doubled in the 39% of the sample with hyperinsulinemia (hazard ratio (HR) = 2.1; 95% 
CI: 1.5, 2.9) and was highest in people without diabetes indicating that higher insulin 
levels were related to the risk of dementia and particularly the cases with diabetes with 
highest HR was noticeable finding which adds a strong evidence of independent 
association between insulin resistance and AD (13, 63).  
In addition, the population-based cohort study (1990-1991) of 959 elderly subjects 
from eastern Finland on the association of metabolic syndrome with AD by Vanhanen et 
al. provides more evidence for the independent association (89). They found that 
metabolic syndrome was significantly associated with AD in multivariate logistic 
regression analysis (OR = 2.46; 95% CI 1.27 to 4.78) and also this significant association 
appeared in people without diabetes (OR = 3.26; 95% CI 1.45 to 7.27) (89).   
In summary, insulin resistance may increase the risk of age-related memory 
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impairment and AD through possible mechanisms mentioned above and many evidences 
from population-based studies give the possibility of its independent association to AD 
among non-diabetes.  
 
The role of glycemic index/ glycemic load  
in insulin resistance and type II diabetes 
Carbohydrates have been traditionally classified as ‘simple carbohydrates’ or 
‘complex carbohydrates’ based on their chemical structure (the length of sugar compound 
chain) (90). Simple carbohydrates that have one or two sugar molecule (mono or 
disaccharides) such as fruit sugar (fructose), corn sugar (glucose), and table sugar 
(sucrose), which are considered as ‘bad carbohydrates’ whereas complex carbohydrates 
that are considered ‘good carbohydrates’ include any sugar molecules that have more 
than three linked sugar compounds (polysaccharides) (90).          
However, most digestible carbohydrates can be converted into glucose to be used 
as an energy source for the body. Therefore, the judgment of carbohydrate as ‘good’ or 
‘bad’ by old assumption is ambiguous because it does not explain how different types of 
carbohydrates physiologically affect plasma glucose and insulin responses, thereby, 
implicating health effects. For this reason, GI was proposed in 1981 by Jenkins et al to 
classify carbohydrate-containing foods according to their postprandial glycemic effect 
which has a basic idea that food sources of carbohydrate vary greatly in their rate of 
absorption and physiological effects on blood glucose and insulin concentrations (27, 91). 
GI is defined as an index of the postprandial glucose response of a food, compared 
with a reference, usually glucose or white bread (92). It represents the incremental area 
under the curve of blood glucose produced by a standard amount of carbohydrate in a 
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food (test food), usually 50g, relative to the incremental area produced by the same 
amount of carbohydrate from standard source (reference food), usually white bread or 
glucose as shown in Figure 1 and the formula for GI calculation is as follows: (27, 92)  
GI = (Blood glucose area under the curve (AUC) of test food/ blood glucose AUC of 
referenced food) x 100 (92). 
It is determined by feeding 10 or more healthy people a portion of the food 
containing 50 grams of digestible carbohydrate after an overnight fast and then finger-
prick blood samples are taken at 15-30 minute intervals to measure the effect on their 
blood glucose levels over the next two hours so that for each person, the area under their 
two-hour blood glucose response (glucose AUC) for the test food is measured (93).   
 
 
 
Figure 1. Measurement of Glycemic Index (cited from www.glycemicindex.com) 
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On the other hand, the same 10 people consume an equal-carbohydrate portion of 
glucose sugar (the reference food) and their two-hour blood glucose response is also 
measured and then a GI value (% ranking) for the test food is then calculated for each 
person by dividing their glucose AUC for the test food by their glucose AUC for the 
reference food and then multiplying by 100. The final GI value for the test food is the 
average GI value for the 10 people (93).   
GI is a ranking of carbohydrates on a scale from 0 to 100 according to the extent to 
which they raise blood glucose levels after intake of carbohydrate-containing foods.  
Foods with a high GI (greater than 70) indicate that they are rapidly digested and 
absorbed and result in a marked increase in blood glucose levels. On the contrary, low-GI 
foods (less than 55) are slowly digested and produce gradual rises in blood glucose and 
insulin levels. 
    Augustin et al. described the factors that may affect GI values, as follows: ratio of 
amylase to amylopectin present in the raw food (more amylopectin, higher GI), the type 
of monosaccharide components (glucose ↑ or fructose ↓), the amount and type of dietary 
fiber (increasing soluble fiber, decreasing GI), cooking and food processing, particle size 
(more processing, increasing GI), ripeness, α-Amylase inhibitors such as phytic acid, 
lectins, and tannins (↓ GI), and the presence of large amounts of fat or protein (↓ GI) (94). 
 Assessment of carbohydrate quality using glucose as the reference was made with 
international Table that contained more than 500 foods was produced by Foster-Powell 
and Brand-Miller et al. at the University of Sydney in 1995 and then it was revised and 
compiled to “ International Tables of Glycemic Index and Glycemic Load Values: 2002”   
which was containing nearly 1300 data entries representing more than 750 different types 
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of foods (91).   
2002 version of GI table contained mainly carbohydrate foods that were classified 
into twenty two food groups (91). There were no GI values in the table for foods 
containing little or no carbohydrate such as meat, fish, eggs, avocados, cheese, and salad 
vegetables because clinical determination of GI is required a person to consume a serving 
of food containing at least twenty five to fifty gram of carbohydrate (95). 
Glycemic load (GL) was first introduced in 1997 by Willett et al. at Harvard 
School of Public Health and is defined as a measure that incorporates both the quantity 
and quality of dietary carbohydrate (27, 92). GL is calculated by multiplying the amount 
of carbohydrate by its glycemic index and the formula is as follows (27, 92): 
GL = (GI of individual food x g carbohydrate per serving of food)/ 100 (92).   
Each unit of dietary GL represents the equivalent of one gram of carbohydrate from 
white bread or glucose (96). Physiological implication of GL is that the GI is more 
important when carbohydrate intake is high (27). Dietary glycemic load can be estimated 
as the sum of the glycemic loads of all carbohydrate foods consumed during a day (27, 
97). Brand-Miller et al. validated the concept of GL with the clinical trial in lean young 
adults (97) and Galgani et al. showed GL was useful in predicting the acute impact on 
blood glucose and insulin response within mixed meals (98). 
There have been existing continuous criticisms on the glycemic index concept such 
as GI values in the mixed meals (difference in GI value will be lost in mixed meal due to 
the effects of protein and fat contents). It is less practical application to people due to its 
difficult concept and potential dietary restriction, and issue on beneficial foods with high 
GI (99).   
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Kendall et al. and Willett et al. addressed these issues. For the first issue on GI 
values in the mixed meals, the study results from Wolever et al. and Bornet et al. have 
shown that fat and protein did not affect the relative differences between carbohydrate-
containing foods (27, 99-101). Willett et al. explained the way of calculation in the total 
GI from mixed foods as a weighted average of the GI values of the individual foods, with 
the weights corresponding to each food’s carbohydrate content (27).   
In the recent study, Wolever et al. ascertained their finding with the use of 
crossover design in both Sydney and Toronto and concluded that GI was a significant 
determinant of the glycemic effect of mixed meals in normal subjects and GI explained 
approximately 90% of the variation in the mean glycemic response, with protein and fat 
having negligible effects (28). 
For the second issue, Kendall et al. answered that GI might simply be used as a tool 
for selecting better quality starchy foods (99). For the last issue, some foods, such carrots 
have been condemned because they have a high GI, but maybe, this issue can be 
explained with GL concept from Willett et al.   
The glucose and insulin responses depend on both the quantity and quality of the 
carbohydrate and GL represents both of these components of carbohydrates, thus even 
though carrots have high glycemic index, GL of carrots is very low because they have 
small amount of carbohydrate implicating little impact on blood glucose (27, 99). In 
general, low calorie foods such as fruits and vegetables that have high GI tend to have no 
significant effect on blood glucose levels and they also have high levels of beneficial 
factors such as fiber, vitamins, and minerals (99). Therefore, GI may be a useful tool for 
selecting better quality starchy foods and GL may be more relevant to apply the concept 
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of GI to whole mixed meals and overall diet.  
GI and GL have been related to chronic diseases such as insulin resistance, type II 
diabetes, coronary heart disease (CHD), obesity, colon cancer, and breast cancer (94).  
Because GI was driven by the effects of carbohydrate-containing foods on blood glucose 
and insulin concentration, GI and GL have been associated with insulin resistance but not 
all, type II diabetes, and metabolic syndrome in clinical trials, large prospective cohort 
studies, and population-based cross-sectional studies. 
Epidemiological evidences from Nurses’ Health Study and Health Professional 
study by the same group, Salmeron et al. showed a significant association between GI 
expressed as GL and risk of diabetes that diets with a high glycemic load and a low cereal 
fiber content increased risk of diabetes in both men and women (18, 19).   
In the other cohort study, Meyer et al. followed 35,988 women who completed the 
same dietary questionnaire used in the Nurses’ Health Study for 6 years and found that 
total carbohydrates intake, GI, GL, fruits & vegetables were not associated with risk of 
diabetes whereas whole-grain intake and cereal fiber were inversely associated with 
diabetes (102). In response to this finding, Willett pointed out the lack of association with 
GI or GL in Meyer’s study may have been related in part to use of a single measure of 
dietary intake and self-reported diabetes without confirmatory information (27). 
The relation between whole-grain consumption and the risk of type II diabetes 
among women in the Nurses’ Health Study was examined by Liu et al. who has 
collaborated with the Harvard study group and the results were that women in the top 
quintile of whole-grain intake (median: 2.7servings/d) had a 27% lower risk of diabetes 
than did those in the lowest quintile (median: 0.13 serving/d) and the ratio of refined to 
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whole grains was significantly associated with risk of diabetes (103). Follow-up study of 
42,898 men from the Health Professionals reported the same confirmative results with 
Lie by Fung et al who again involved in the same study group (21).   
The Nurses’ Health Study II by Schulze et al. examined the association between GI, 
GL, and dietary fiber and the risk of type II diabetes in a large cohort of young women 
and they found that GI was significantly associated with an increased risk of diabetes and 
cereal fiber intake was associated with a decreased risk of diabetes but GL was no 
significant association (26). 
In the other cohort study, McKeown et al. examined the cross-sectional association 
between whole- or refined-grain foods and several metabolic markers of disease risk in 
their early Framingham Offspring Study and found that increased intakes of whole grains 
was inversely associated with reduced metabolic risk factors (104) and then their follow-
up study explored the associations between carbohydrate-related dietary factors including 
total dietary carbohydrate, fiber, whole- and refined-grain foods, GI, and GL, insulin 
resistance, and the prevalence of the metabolic syndrome in 2,834 subjects at the fifth 
examination (1991-1995) (23). Their results were continuum of similar results that 
whole-grain intake, largely attributed to the cereal fiber, was inversely associated with 
Homeostasis model assessment of insulin resistance (HOMA-IR) and a lower prevalence 
of the metabolic syndrome but GI was appeared as an opposite result (23). Sahyoun et al. 
from the same cohort study examined the same cross-sectional association in older adults 
aged 60-98 years and the results showed a significant inverse association between whole-
grain intake and metabolic syndrome and mortality from CVD (24). 
An interesting cross-sectional study from Japan examined the cross-sectional 
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association between GI and GL and several metabolic risk factors including BMI, fasting 
triacylglycerol, fasting blood glucose, and glycated hemoglobin in healthy Japanese 
women with traditional dietary habits (105). They found that GI was positively associated 
with BMI, fasting blood glucose, and glycated hemoglobin while GL was independently 
negatively associated with HDL and positively associated with fasting triacylglycerol and 
glucose (105). Negative correlation between GL and HDL was a noticeable finding, but it 
was a snap-shot observation from Japanese female farmers, therefore further long-term 
observation may be needed.  
With the stream of whole grains study, cross-sectional study of Jenson et al. 
examined the association between whole grains, bran, and germ in relation to 
homocystein and markers of glycemic control, lipids, and inflammation among healthy 
sub-samples (n = 938) from the Health Professionals Follow-up Study and the Nurses’ 
Health Study II and found that whole grains intake was inversely associated with 
homocystein, total cholesterol, the most strongly with glycemic control, but not 
associated with markers of inflammation (106).  
However, Qi et al. found a significant association between whole grains, GI, and 
GL and plasma biomarkers of inflammation among 902 diabetic women in the same 
study group, the Nurses’ Health Study (107). In a meta-analysis of randomized controlled 
trials, Brand-Miller et al. searched 14 studies comprising 356 subjects and all were 
parallel experimental design of 12 days’ to 12 months’ duration with modification of at 
least two meals per day (108). The result was that low-GI diets reduced Hemoglobin A1c 
by 43% indicating the effect of low-GI diets was small but clinically useful for the 
glycemic control in patients with diabetes (108). Table 3 summarized population-based 
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prospective and cross-sectional studies and one meta-analysis of clinical trials. 
Table 3. Reports from prospective cohort & cross-sectional studies examining the 
relationship between dietary glycemic index & glycemic load and chronic diseases 
Reference Study 
design 
N Disease state Difference in 
parameter  
Association RR 
or OR 
Note 
Salmeron,  
1997 
(18) 
Cohort 
(6 yrs) in 
men 
42759 Type 2 
diabetes 
Quintiles in 
GI 
GI, RR 1.37 
(1.02-1.83) 
Comb, RR 2.17 
(1.04-4.54) 
Significance for 5th 
quintile of GI after 
adjusting fiber 
Highly significant in 
combination of GL & fiber 
Salmeron,  
 1997 
(19) 
Cohort 
(6 yrs) in 
women 
65173 Type 2 
diabetes 
Quintiles in 
GI 
RR 1.37 (1.09-
1.71) 
Significance for 5th 
quintile of GI after 
adjusting fiber 
Liu, 2000 
(103) 
Cohort 
(10 yrs) in 
women 
75521 Diabetes Quintiles in 
whole grains 
RR 0.62 for 
whole grains 
RR 1.31 for 
refined grains 
 
More significance in 
women BMI > 25 
Fung , 
2000 
(21) 
Prospecti
ve cohort 
(≥12 yrs) in 
men 
42898 Type 2 
diabetes 
Quintiles in 
whole-grain 
intake 
RR 0.57 (0.48-
0.69) 
Significance for 5th 
quintile of whole-grain 
intake after adjusting age; 
inverse association-can be 
modified by BMI 
Schulze, 
2004 
(26) 
Prospecti
ve cohort 
(for 8 yrs) 
in young 
women 
91249 Type 2 
diabetes 
Quintiles in 
GI, GL, fiber 
RR GI 
1.59(1.21-
2.10)/fiber 0.64 
(0.48-0.86)  
GI – significant positive  
Fiber – inverse assoc. 
GL – no significant 
(RR; 1, 1.31, 1.20, 1.14, 
and 1.33, p=0.21) 
Mckeown, 
2004 
(104) 
Framing
ham 
offspring 
cohort 
(1991-95) 
2834 Insulin 
resistance & 
metabolic 
syndrome 
Quintiles in 
GI, GL, whole-
grain, fiber 
OR; cereal fiber 
0.62 
whole-grain 
0.67, GI 1.41 
Significance for 5th 
quintile of GI, whole-
grain, largely from cereal 
fiber. Whole-grain intake↓ 
HOMA-IR & metabolic 
syndrome 
Sahyoun, 
2006 
(24) 
Cohort 
(1981-
1984) in 
older adult 
535 Metabolic 
syndrome, 
CVD, mortality 
from CVD 
Quartiles in 
whole-grain 
whole-grain 
OR 0.46 for 
metabolic 
RR 0.48 for 
CVD mortality 
Significance for 4th 
quartile of whole-grain 
intake & refined grains 
Murakami, 
2006 
(105) 
Cross-
sectional 
study in 
Japanese 
women 
1354 
 
Type 2 
diabetes & CVD 
  GI & GL are 
independently correlated 
with several metabolic 
risk factors (GL inversely 
associated with HDL) 
Jenson, 
2006 
(106) 
Cross-
sectional 
study 
938 Diabetes, 
inflammation, 
IHD 
Quintiles in 
homocystein, 
plasma markers 
 Whole grain diet lower 
risk of diabetes, heart 
disease, but not 
inflammation 
Qi, 2006 
(107) 
Cohort 
in women 
902 Diabetes 
inflammation 
Quintiles in 
GI 
 
 Whole grains and low 
GI diet reduce the risk of 
systemic inflammation in 
type 2 diabetes women 
Brand-
Miller, 
2003 
(108) 
Meta-
analysis of 
randomized 
controlled 
trials 
356 
(14 
trials) 
Diabetes  HbA1c ↓ 40% 
by low GI diet 
The use of Low GI diet 
to improve glycemic 
control in practice – the 
effect was samall, but 
useful in clinical setting. 
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There were also contradicting findings that did not support the hypothesis that a 
high-GI leads to diabetes. In the Iowa Women’s Health Study by Meyer et al. (102) and 
the Atherosclerosis Risk in Communities Study by Stevens et al. (109), neither GI nor GL 
showed any association with diabetes risk. 
In conclusion, although a few studies have reported contradicting findings, 
substantial evidence from population-based cohort studies has accumulated showing that 
the long-term consumption of high GI and GL diet can adversely affect metabolism and 
health (110). Cordain et al pointed out that chronic exposure in hyperglycemia and 
hyperinsulinemia induced by high GL diet may promote insulin resistance and the 
metabolic syndrome (110). 
 
Link between glycemic index / glycemic load  
and Alzheimer’s disease via its role in insulin resistance  
and type II diabetes 
 
Diabetes and insulin resistance (hyperinsulinemia) have been associated with an 
increased risk of AD in clinical experiments, population-based cross-sectional study or 
cohort study, as well as animal studies. Dietary intake of foods containing carbohydrates 
that are rapidly absorbed from the gastrointestinal tract thereby increase blood glucose 
levels and affect insulin concentrations in terms of high in GI and GL have been 
associated with an increased risk of type II diabetes and metabolic syndrome through 
insulin resistance and hyperinsulinemia.   
Syllogistically the hypothesis that GI and GL may be associated with risk of AD 
via insulin resistance can be made. The growing body of study has related nutrients to 
cognitive decline and AD through epidemiological studies, particularly focusing on 
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individual dietary nutrients such as homocystein-related B vitamins (folate, vitamin 
B6,12), antioxidants (vitamin E, C, carotenoids, flavonoids, enzymatic cofactors), dietary 
lipids (poly-, mono-unsaturated fat, and DHA (mainly fish), EHA) (35). However, there 
has been little invested in the research for this association between GI & GL and AD.   
Only two studies were found: one large cohort and one small clinical trial, but they 
had a conflicting result. In the clinical trial, Greenwood et al. examined the impact of 
acute carbohydrate consumption on memory impairment among 19 adults with type II 
diabetes and they found that poorer glycemic control is associated with lower 
performance on tests of declarative memory and acute ingestion of high GI foods further 
contributed to the underlying memory impairment (111). Contrary, in the cohort study, 
Luchshinger et al. explored the relation of GL with AD risk among 939 elderly people 
without dementia for 6.3 years, but the result was that higher risk of AD was associated 
with only total calories, not GL (37). 
Prospective cohort studies from the Cache County Study on Memory, Health and 
Aging, CHAP study, Kame project, and WHICAP study focused on the relation between 
food groups or dietary patterns and cognitive decline and dementia (37). Not all (CHAP 
study found no fruit-cognitive change association), but the results from three large 
prospective cohort studies provided evidence for the inverse association between fruits, 
vegetables and fish intake and risk of AD or MeDi diet and risk of AD (39, 41). 
Interestingly, carbohydrate foods of inversely associated with risk of AD and the 
carbohydrate components in diet (MeDi) are both mutual in low or medium GI/GL foods.   
GI & GL have been used as a tool to measure physiological effect of carbohydrates 
intake related to insulin resistance and DM. Insulin resistance and type II diabetes have 
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been linked with increased risk of AD with substantial evidences. However association 
between AD and insulin resistance or AD and type II diabetes were not always provided 
from prospective cohort studies and clinical trials. Similarly, with existing controversies 
and much debate among researchers, the findings of association between GI/ GL and 
insulin resistance and DM have been outnumbered non-significant ones. Based on this 
premise, GI/GL can be linked to the risk of AD and a hypothesis that low GI & GL diet is 
associated with reduced risk of AD can be established. If the finding of this research 
provides evidence of hypothesized association, dietary GI/GL may contribute an 
important role in preventing or delaying cognitive impairment and AD. 
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RESEARCH OBJECTIVE 
 
 
The objective of this study is to find a possible relationship between dietary 
glycemic load intake and Alzheimer’s disease based on the premise as follows: 
association between high glycemic index and glycemic load and the risk of insulin 
resistance and type II diabetes, and association between insulin resistance and type II 
diabetes and the risk of Alzheimer’s disease. Therefore, the hypothesis to be tested is that 
high glycemic load diet is associated with increased risk of incident Alzheimer’s disease. 
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SUBJECTS AND METHODS 
 
 
Study participants 
     The Cache County Study on Memory, Health and Aging is a population-based, 
prospective cohort study of the prevalence and incidence of dementia and Alzheimer’s 
disease (AD) among the Cache County elderly people of Northern Utah, was established 
in 1994, and has been funded by the United States National Institute on Aging (3, 41). 
The study has been collaborated with Duke University at the beginning, John Hopkins 
University, Harvard University, the University of Washington, Brigham Young University, 
and the University of Utah later (3).    
There were 5,092 participants (ninety percent) among 5,677 Cache County 
residents aged sixty five years or older (mean age, 74.9 years for men and 76.5 years for 
women) at the baseline examination (3, 41, 62) . Approximately 90 percent of elderly 
Cache County people are members of The Church of Jesus Christ of Latter-day Saints 
(LDS or Mormon) (3). Their religion forbids smoking, drinking alcohol, and caffeinated 
drink such as tea and coffee. This life style may contribute to the health effects thereby a 
long-life span. Because of a long-life span compared to other states, rates of AD are 
projected to rise 127 percent by 2025 (3).   
The participants completed the baseline interview regarding demographic 
characteristics, medical history, occupational history, family history of dementia, diet, 
smoking, alcohol use, and other lifestyle factors between 1995 and 1996 (3, 41). The 
APOE ε-4 alleles genotyping was examined by a cheek-swab DNA sample from the 
participants (41). 
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Demographic characteristics of participants including age, gender, body max index 
(BMI = Weight in kg/ (Height in meter)2), diabetes, myocardial infarction (MI), stroke, 
education, physical activity (indicator of moderate physical activity), smoking, alcohol 
use, and APOE ε-4 genotype obtained from the baseline interview were used as non-
dietary covariates in this data analysis. 
 
Diagnosis of dementia and Alzheimer’s disease 
Cognitive screening was assessed in the baseline interview (1995) and four follow-
up screenings were conducted during 1996-1997 (Telephone) 1998-1999 (Wave 2), 2002-
2003 (Wave 3), and 2006-2007 (Wave 4) (3, 62). The Modified Mini-mental State 
Examination (3MS) was used to assess cognitive function and to screen for dementia (41). 
If participants scored below a sensory adjusted cut-point at any time points of screening, 
then all suspicious cases of dementia went on the sequential multi-stage screening to 
diagnose prevalence and incidence of dementia and AD. Final clinical diagnoses for 
dementia and AD were appointed by consensus conferences including geropsychiatrists, 
neuropsychologists, a neurologist, and a neuroscientist (3). Incidence of AD was 
measured as new cases of AD during the time period of wave 2, wave 3, and wave 4 
among participant without dementia and AD at the baseline. The data for the incident of 
AD we used was collected after the baseline screening to the time point somewhere 
between wave 3 and wave 4.  
 
Diet assessment  
At the baseline examination, 3831 dietary Food Frequency Questionnaires (FFQ) 
were collected among 5,092 participants because 355 people who were scored below the 
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cutoff for the 3MS at the baseline cognitive screening were not received FFQ and 3,831 
people among remaining 4,737 participants returned the FFQ. Of those, 3,634 persons 
remained after excluding 197 persons who reported implausible dietary data (daily 
calorie intake less than 500 kcal and more than 5000 kcal), diagnosed as an additional 
prevalent dementia after clinical assessment, and two persons who did not participate the 
baseline dementia screening (41). The final sample data of 3634 participants including 
1,564 men and 2,070 women from the baseline examination were used to estimate usual 
dietary intake of carbohydrates in terms of GI and GL and other macro-nutrients 
characteristics. 
Assessment of usual daily dietary intake was examined with self-reported a 142 
food item Food Frequency Questionnaire (FFQ) as shown in Appendix. FFQ used in the 
Cache County Study was based on the semi quantitative FFQ developed by the Nurses’ 
Health Study (NHS). The reproducibility of the NHS FFQ was evaluated among 38,121 
elderly women aged from fifty five to sixty nine years in the Iowa Woman’s Health Study 
by Munger et al. (41, 112).  
The FFQ we used had 142 food items and a specified portion size for each food 
item (e.g., 8oz. of skim milk). Some food items with ambiguous portion size or without 
portion size were referred to the nutritional professionals and the registered dietitian (RD). 
There were nine possible responses ranging from “NONE OR LESS THAN 1 PER MO.” 
to “6 PER DAY.” Nutrient values for all food items in the baseline FFQ were derived 
from the ESHA program, 1997 version.  
Glycemic Index Table and a web site maintained by Sydney University were used 
as primary sources to assign GI values to foods (91, 93). There are two GI values: one for 
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If not 
142 Food list 
from FFQ 
1. Direct link to GI table 
2. Impute GI value of 
closely related foods 
If not 
If not 
3. Impute vegetable 
mean if it is vegetable 
4. Use weighted mean of 
GI’s ingredients if mixed 
foods 
5. Impute GI value from 
top 90% Carb 
contributors from Flood’s 
table if food item is 
linked to them 
6. Impute 50 if not linked to 
any food item, but has Carb 
7. Impute 0 if food item 
have no Carb 
Carb: carbohydrates 
glucose referenced and one for white bread referenced for each food. This study used 
glucose referenced GI value. If food items were not in the GI tables, the method to 
determine GI values for those food items were referred to the methodology created by 
Flood et al. Their article published in 2006 described nine-steps of an algorithm linking 
GI values to foods, but this study set the seven steps based on their methods (Figure 2) 
(95).  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 2. Seven steps of algorithm in linking GI values (cited from Flood, 2006 (95)) 
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The ESHA program had a nutrient database per 100 grams of food, so the gram of 
carbohydrate for each food item (Carb) was calculated as follows: CHO = (total gram of 
each food/ a portion on FFQ x carbohydrate content per 100 gram of each food from 
ESHA data base)÷100. Other nutrients for each food item per portion were calculated by 
the same way. And then, nutrient intakes were computed by multiplying the frequency 
response by the nutrient content of the specified portion sizes.  
A separate table for the Ready to Eat Cold Cereal (RTECC) was made because 
RTECC had a great variety in types as well as in amounts of carbohydrates. RETCC table 
contained 62 different types of cereal list and nutrient values were also derived from the 
1997 version of ESHA program. GI value for each cereal was assigned from the 
Glycemic Index Table and if there is no GI value for certain type of cereal, the GI value 
of the cereal with closed amounts in carbohydrate, fiber, and sugar content was given. 
And then this table was merged into the original Food table. 
Finally two tables, food table including nutrients content of 142 food item per 100g 
as well as GI value for the each food item and data base input file which had total gram 
of carbohydrates of 142 food items consumed by participants per day, were prepared to 
calculate total glycemic load (GL) per day (dietary GL intake per day). We used the 
FoodCalc program written by Jasper Lauritsen to make cross these tables and to calculate 
total dietary GL intake for 3634 participants (113).   
GL for each food item in each participant was calculated by multiplying the final 
grams of carbohydrate from the carbohydrate content for each portion of food times the 
average number of servings of that food per day by the food’s GI value. Total dietary GL 
for each participant then was produced by summing the GL scores over all food items.  
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Statistical methods 
     Statistical analyses were conducted with SPSS 15.0 for Window software program. 
Descriptive statistic analysis was used to see normality of the distribution of total 
glycemic load (GL), the demographic and nutrient characteristics of participants, and 
correlations of GL with other dietary variables at the baseline. The demographic, clinical, 
and dietary characteristics were crossed by gender and then demographic and clinical 
characteristics were crossed by kcal adjusted GL quintiles separately in gender. Energy 
adjusted GL was calculated as follows:  
Kcal adjusted GL = (total GL/total kcal) x 1000 = GL/1000kcal 
We analyzed most of data separately by gender because men and women had very 
different characteristics in many aspects.  
Continuous variables such as age (years), BMI, total kcals, total carbohydrates (g), 
total fiber (g), total sugar (g), total protein (g), and total fat (g) were compared using one-
way ANOVA test, and categorical variables such as dementia (all dementia types, 0/1 
indicator), gender, education (< high school or > high school), diabetes (yes or no), 
smoking (yes or no), alcohol use (yes or no), APOE ε-4 alleles (0 – 2 copies), and 
moderate physical activity (3 levels: everyday or 2-6 times per week, 1-4 times per week, 
and rare) were compared using chi-squared test. 
Distribution of diabetes crossed GL quintiles stratified by gender as well as 
distribution of dementia among diabetes was examined to look at whether diabetes is a 
confounding factor or not. Distribution of dementia among GL quintiles stratified by 
gender and diabetes was also examined to look at the association between diabetes, 
dementia, and GL. And then, the same test was conducted after exclusion of 464 diabetes 
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cases by assuming diabetes as a confounder. Finally the same procedure, but with 
different GL categories (dichotomy): the first group for the first quintile and the second 
group for the upper groups (Quintiles 2-5), was conducted to examine the association 
between dietary lower GL intake and the risk of dementia. 
Survival analysis: Cox proportional hazards regression models were used in 
univariate and multivariate analyses exploring the relation of GL with AD. The time to 
event variable represents time from the baseline dietary assessment to incident AD. We 
used a time variable with the time of age onset. Persons who were lost to follow-up or did 
not develop dementia were censored at the last time of follow up (code = 0). Persons who 
developed dementias coded according to the type of dementia (1 = pure AD, 2 = primary 
VaD with secondary AD, 3 = VaD: vascular dementia, and 4 = other types of dementia). 
Estimated hazard ratios (HRs) for AD with the dichotomy of GL using the lower group 
(the first quintile group, 20%) as the reference was used to compare with upper groups 
(quintile 2 – 5, 80%). 
The study used the univariate and multivariate analyses for two models: one (I) for 
the raw model and one (II) adjusted for covariates including education, MI, stroke, BMI, 
physical activity, smoking, alcohol, APOE ε-4 alleles, and multi-vitamins use. Genders 
were split before running Cox hazard regression models. To detect confounding factors 
among nutritious factors, at first, Cox hazard regression was used to compare hazard ratio 
between nutritious factors and incident AD and an adjustment technique was used and the 
results from adjusted estimate were compared to the crude result.  
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RESULTS 
 
 
      Frequency distribution in the histogram from the descriptive analysis of glycemic 
load (GL) showed right skewness in Figure 3. After adjusted energy, the distribution of 
GL became normal (skewness = 0.096) as shown in Figure 4. 
 
 
 
Figure 3. Frequency distribution in total glycemic load before energy adjustment 
 
 
 
 
Figure 4. Frequency distribution in total glycemic load after energy adjustment 
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Table 4 includes overall demographic and clinical characteristics of valid 
participants at baseline by gender before energy adjustment. Of the total participants, 
approximately 57 percent were female and mean age for men and women was 74.2 years 
and 75.0 years. Mean BMI for men and women were 26.4 and 26.1 which both belong to 
over-weight category (BMI ≥ 25: over-weight, BMI ≥ 30: obese). There is no gender 
difference in mean BMI. The majority of participants had attained at least a high school 
education or higher (81.5 percent for men and 86.6 percent for women) and more women 
were educated at the level of high school or greater. Seventy-two percent of men and 65.5 
percent of women had a moderate physical activity every day or two to six times per 
week, so more men were appeared physically active. Over 90 percent of women reported 
never having smoked cigarettes and consumed alcohol, but men reported that over 70 
percent never drank alcohol and over 60 percent never smoked cigarettes. Self-reported 
diabetes was 14 percent for men and 12 percent for women. Additional characteristics of 
participant by gender are listed in Table 4.  
Table 5 includes characteristics of dietary and macro-nutrients obtained from the 
baseline FFQ. Mean total GL per day for men and women were 147 (SD = 60.1) and 138 
(SD = 58.3). Energy adjusted GL was 72.1 (SD = 11.4) for men and 73.8 (SD = 11.4) for 
women. Mean total GL intake was greater in men, but it was greater in women after 
energy adjustment. Mean total kcals for men and women were 2048 (SD = 785.6) kcals 
and 1882 (SD = 763.9) kcals. Other characteristics such as carbohydrate, fiber, sugar, 
protein, fat, and use of multi-vitamins are listed in Table 5. Noticeable thing is overall 
macro-nutrients mean intake was higher in men but fiber mean intake was the same in 
both men and women.  
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Table 4. Demographic and clinical characteristics of baseline  
in the Cache County Study on Memory, Health, and Aging by gender 1 
Characteristics Male Female 
  (n = 1564) (n = 2070) 
Total glycemic load** 147.2 ± 60.12 138.0 ± 58.3 
Glycemic load/1000 kcals** 72.1 ± 11.4 73.8 ± 11.4 
Age** 74.2 ± 6.5 75.0 ± 6.8 
BMI (kg/m2)* 26.4 ± 3.9 26.1 ± 4.8 
8.1 9.3 Dementia (%)3         Yes 
                   No 91.9 90.7 
14.0 12.0 Diabetes (%)*         Yes 
                   No                   86.0 88.0 
17.5 8.8 MI (%)**             Yes                                           
No 82.5 91.2 
3.7 3.0 
0.8 0.5 
Stroke (%)         Probable 
                Uncertain  
                     No 95.6 96.4 
Education (%)**    
> High School 81.5 86.6 
< High School 18.5 13.4 
Physical Activity (%) **    
      Everyday or 2-6x/week 76.2 65.5 
           1-4 times/ month 12.8 17.5 
                     Rare 11.0 17.0 
65.2 93.1 
31.5 5.5 
Smoking (%) **       Never  
Former 
Current 3.3 1.4 
72.7 92.5 
20.8 5.1 
Use Alcohol (%) **    Never  
Former 
 Current 6.5 2.3 
67.7 69.2 
29.2 29.0 
APOE ε-4 alelles     0 copy  
                   1 copy  
                  2 copies  3.1 1.9 
1
 Distribution of demographic and clinical covariates of baseline 
population by gender 
 
2
 Mean ± standard deviation (SD)   
** Significant difference between geder, p < 0.000   
* Significant difference between geder, p < 0.05   
3 Dementia = Incident dementia between wave 3 and 4, not prevalent dementia 
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Table 5. Dietary and macro-nutrients characteristics of baseline  
in the Cache County Study on Memory, Health, and Aging by gender 1 
  Male Female 
Dietary Characteristics (n = 1564) (n = 2070) 
Total kcals* 2048.8 ± 785.62 1882 ± 763.9 
Total carbohydrates* 268.3 ± 106.0 255.1 ± 106.8 
Total fiber 19.0 ± 9.2 19.6 ± 10.2 
Total sugar* 136.8 ± 63.1 129.3 ± 63.5 
Total protein* 87.8 ± 35.6 82.9 ± 37.1 
Total fat* 74.0 ± 34.9 64.2 ± 31.9 
Total glycemic load* 147.2 ± 60.1 138.0 ± 58.3 
Glycemic load/1000 kcals* 72.1 ± 11.4 73.8 ± 11.4 
Use Multi-Vitamins (%)*   
Yes 38.6 45.8 
No 61.4 54.2 
1
 Distribution of dietary covariates of baseline population by gender 
2
 Mean ± stan between gender, p < standard deviation (SD), all macro-nutrients are in gram 
* Significant difference 0.000 except Total fiaber (p=0.07) 
 
The range of correlations was greatly changed between GL and other dietary 
characteristics after energy adjustment, but GL was still correlated with carbohydrates 
and sugar intake, moderately correlated with fiber, and negatively correlated with protein 
and fat intake in Table 6 and Table 7. Correlation between energy (kcals) and other 
macro-nutrients ranging from 0.45 to 0.90 were not significantly changed after energy 
adjustment. 
Table 8 and Table 9 separately show the demographic and clinical characteristics 
among energy adjusted GL quintiles by gender. In men, GL was significantly associated 
(p<0.000) with diabetes, smoking, and alcohol use, and moderately associated (p<0.05) 
with education and physical activity. Other covariates including age, BMI, dementia, MI, 
stroke, and APOE ε-4 alleles were not associated with GL. In women, GL was 
significantly associated with diabetes, and alcohol use, moderately associated with age, 
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BMI, and smoking, not associated with other covariates. 
  
Table 6. Correlations of glycemic load (GL) with other dietary variables 
  GL Kcals Protein Carb Fiber Sugar Fat  
GL 1        
Kcals .919(**) 1      
Protein .683(**) .869(**) 1      
Carbohydrates .984(**) .927(**) .718(**) 1     
Fiber .698(**) .687(**) .612(**) .779(**) 1    
Sugar .865(**) .792(**) .580(**) .902(**) .676(**) 1   
Fat .728(**) .908(**) .779(**) .713(**) .454(**) .561(**) 1  
** Correlation is significant at the 0.01 level (2-tailed). Carb=carbohydrates 
 
 
 
Table 7.Correlations of energy-adjusted glycemic load with other dietary variables 
  
GL   Kcals Protein Carb Fiber Sugar Fat 
GL 1       
Kcals 
-.092(**) 1      
Protein 
-.349(**) .868(**) 1     
Carbohydrates 
.220(**) .927(**) .713(**) 1    
Fiber 
.086(**) .693(**) .616(**) .779(**) 1   
Sugar 
.241(**) .789(**) .570(**) .898(**) .664(**) 1  
Fat 
-.327(**) .907(**) .779(**) .712(**) .463(**) .562(**) 1 
** Correlation is significant at the 0.01 level (2-tailed). Carb=carbohydrates 
 
In current alcohol users in both men and women, percentage of people in current 
use was notably decreased with increasing quintiles. On the other hand, never user 
showed opposite direction in Table 8 and Table 9. A similar trend was appeared in the 
current smokers particularly in men. In short, current alcohol user and smoker had the 
lowest GL intake in both genders.  
Table 10 and Table 11 show diabetes as a confounder in the relation between GL 
and AD through diabetes distribution among GL quintiles and dementia rates among 
diabetes. The percentage of diabetes in the lowest quintile (Q1) over the highest quintile 
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(Q2) was almost two times in men (21% vs. 13.6%) and greater than two times in women 
(18.4% vs. 8.2%) in Table 10. Among non-diabetics, overall percentage increased with 
ascending GL quintiles. People with diabetes had a higher percentage of dementia 
compared to non-diabetes in Table 11. Our previous finding in the Cache County study 
showed that diabetes at the baseline was associated with 4 times greater risk for 
developing incident AD among men (RR=4.05, 95% CI:1.84-8.65) than non-diabetics, 
but not in women from the data of W2 observation (62). Thus, this result indicated that 
diabetes is problematic factor to estimate people’s usual carbohydrate intake as well as to 
examine the association between GL and AD. 
Diabetes was tested by cross-tabulating dementia distribution among GL quintiles 
by gender and diabetes status because the observed association between GL and dementia 
(no association in Table 8 and 9) may be affected by diabetes (changing their diet as diet 
treatment). The effect of diabetes may also be appeared differently between male and 
female. As depicted in Table 12, percentage of dementia in the fifth quintile was appeared 
twice of the percentage of the first quintile in non-diabetic men featuring like a dose and 
response-effect; however women had a U-shape in the distribution of percentage of 
dementia among GL quintiles in non-diabetics. There might be a possibility association 
of dementia related to GL in non-diabetic men, but p-value was not significant (p-value < 
0.05). 
Because of possible dose- response effect shown in non-diabetic men in Table 12, 
we had an additional test by grouping GL quintiles into a dichotomy: the first quintile 
(Q1, 20%) versus upper level quintiles (80%, Q2 – Q5). The result showed that dementia 
was significantly associated with GL in non-diabetic men (p = 0.019) in Table 13. 
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 Table 8. Demographic and clinical characteristics among energy-adjusted   
glycemic load quintiles in men   
 
 
Glycemic Load Quintiles 
1 2 3 4 5 
  
Characteristics 
(n=352) (n=327) (n=306) (n=295) (n=284) 
Glycemic Load 57.2 ±.6.1 67.3 ± 1.7 72.8 ± 1.6 78.3 ± 1.8 88.7± 6.2 
Age  73.6 ± 6.4 74.0 ± 6.6 74.6 ± 6.7 74.3 ± 6.2 74.7 ± 6.7 
BMI (kg/m2)  26.9 ± 4.4 26.4 ± 3.5 26.2 ± 4.0  26.2 ± 3.4 26.2 ± 3.9 
Dementia (%)   Yes 6.0 7.0 8.8 10.2 8.8 
No 94 93 91.2 89.8 91.2 
Education (%)*           
> High School 79.5 81 76.5 87.8 83.5 
< High School 20.5 19.0 23.5 12.2 16.5 
Physical Activity (%) *       
Everyday or 2- 6x/week 69.8 76.6 82.2 77.6 75.4 
1-4 times/ month 16.1 14 8.3 14.1 11 
Rare 14.1 9.3 9.6 8.3 13.5 
Diabetes (%) **  Yes 21.0 9.5 11.9 13.1 13.6 
No 79.0 90.5 88.1 86.9 86.4 
MI (%)        Yes 14.0 16.0 16.8 20.8 21.1 
No 86.0 84.0 83.2 79.2 78.9 
Stroke (%)       
Probable 5.5 4.9 2.0 2.4 2.9 
Uncertain 1.2 0.3 1.0 1.0 0.4 
No 93.3 94.8 97.0 96.5 96.7 
Smoking (%) **       
Never 54.0 64.2 70.0 72.2 68.1 
Former 37.4 32.1 29.0 26.8 30.8 
Current 8.6 3.7 1.0 1.0 1.1 
Use Alcohol (%) **       
Never 61.5 70.2 74.3 81.2 79.0 
Former 21.7 22.4 21.4 17.5 20.6 
Current 16.8 7.4 4.3 1.4 0.4 
APOE ε-4 alelles 0copy 67.7 71.6 70.8 63.5 64.5 
1 copy 30.0 26.0 27.2 31.1 31.9 
2 copies 2.3 2.4 2.0 5.5 3.5 
 
 
* p<0.05, ** p<0.000, Mean ± SD (all such values)  
 Physical Activity is moderate activity 
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Table 9. Demographic and clinical characteristics among energy-adjusted  
glycemic load quintiles in women   
Characteristics Glycemic Load Quintiles  
  1 2 3 4 5 
  (n=374) (n=400) (n=422) (n=432) (n=442) 
Glycemic Load range 57.8 ±.6.2 67.6± 1.6 72.7± 1.6 78.5± 1.8 89.5 ± 6.7 
Age * 74.4 ± 6.7 74.7 ± 6.7 75.1 ± 6.6 74.5 ± 6.6 76.2 ± 7.0 
BMI (kg/m2) * 26.5 ± 5.1 26.1 ± 5.0 26.2 ± 4.6 26.1 ± 4.8 25.4 ± 4.6 
Dementia (%)    Yes 12.3 8.5 6.9 9.0 10.0 
No 87.7 91.5 93.1 91.0 90.0 
Education (%) 
     
> High School 84.8 87.8 86.7 86.3 87.3 
< High School 15.2 12.3 13.3 13.7 12.7 
Physical Activity (%)  
     
Everyday or 2-6x/week 65.5 61.4 70.9 66.9 62.8 
1-4 times/ month 16.6 20.2 16.0 15.1 19.4 
Rare 18.0 18.4 13.1 18.0 17.8 
Diabetes (%) **               
     
                Yes 18.4 12.0 11.2 10.9 8.2 
               No 81.6 88.0 88.8 89.1 91.8 
MI (%)            
Yes 10.3 8.0 8.2 9.3 8.5 
No 89.7 92.0 91.8 90.7 91.5 
Stroke (%)    Probable 2.7 2.3 3.6 4.2 2.3 
Uncertain 0.8 0.0 0.7 0.2 0.9 
                 No 96.5 97.7 95.6 95.6 96.8 
Smoking (%) *   Never 90.1 91.0 94.0 93.5 96.1 
 Former 8.0 6.0 4.8 5.6 3.6 
 Current 1.9 3.0 1.2 0.9 0.2 
Use Alcohol (%) ** 
     
Never 88.5 91.0 92.6 93.5 96.4 
Former 7.2 5.0 4.5 6.0 3.2 
Current 4.3 4.0 2.9 0.5 0.5 
     
APOEε-4alelles (%) 0copy 68.5 70.7 65.2 68.9 72.5 
             1 copy 30.5 28.3 31.9 28.3 26.1 
2 copies 1.1 1.0 2.9 2.8 1.4 
* p<0.05, ** p<0.000, mean ± SD (all such values)    
Physical Activity is moderate activities.     
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Table 10. Diabetes distribution among glycemic load quintiles1 
 
stratified by gender  
  
    Glycemic Load Quintiles   
Gender Diabetes 1 2 3 4 5 Total 
Male** Total Count 348.0 326.0 303.0 289.0 280.0 1546 
  
No (%) 79.0 90.5 88.1 86.9 86.4   
  Yes (%) 21.0 9.5 11.9 13.1 13.6   
  
        
Female** Total Count 374.0 399.0 418.0 430.0 441.0 2062 
  
No (%) 81.6 88.0 88.8 89.1 91.8   
  Yes (%) 18.4 12.0 11.2 10.9 8.2   
1
 Energy adjusted glycemic load, ** p < 0.000 
 
    
 
 
 
Table 11. Dementia distribution among diabetes stratified by gender 
    Diabetes Non-diabetes 
Male Dementia (%) 10.35 6.5 
  Non dementia (%) 89.65 94.5 
Female Dementia (%) 11.2 10.25 
  Non dementia (%) 88.8 89.75 
 
 
Table 12. Distribution of dementia among kcal adjusted  
glycemic load quintiles by gender and diabetes 
Gender   Quintiles of Kcal-adjusted Glycemic Load 
  Diabetes  1 2 3 4 5 
   Dementia (%) (n=726) (n=721) (n=728) (n=727) (n=726) 
Male No Diabetes Non-Dementia 95.6 92.2 91.4 90.8 90.9 
(n=1564)  Dementia 4.4 7.8 8.6 9.2 9.1 
  
Diabetes Non-Dementia 87.7 100 88.9 86.8 92.1 
  (n=216,14% ) Dementia 12.3 0.0 11.1 13.2 7.9 
  
 
 
      
Female No Diabetes Non-Dementia 88.2 91.7 93.3 90.9 89.6 
(n=2070)  Dementia 11.8 8.3 6.7 9.1 10.4 
  
Diabetes Non-Dementia 85.5 89.6 91.5 93.6 94.4 
  
(n=247, 12%) Dementia 14.5 10.4 8.5 6.4 5.6 
All p-values were not significant      
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Table 13. Dementia distribution comparison across gender stratified  
by diabetes among energy adjusted GL quintile 1 vs. quintile 2 - 5  
Gender     GL Quintile 1 vs. GL Quintile 2 - 5   
  Diabetes   Q1 Q2 - Q5 p-value1 
    Dementia (%) (n=722) (n=2912)   
Male Non-Diabetes Non-Dementia 95.6 91.4   
(n=1564)  *Dementia  4.4 8.6 0.019 
  
Diabetes Non-Dementia 87.7 91.6   
  
(n=216,14% ) Dementia 12.3 8.4 0.356 
  
      
Female Non-Diabetes Non-Dementia 88.2 91.3   
(n=2070)  Dementia 11.8 8.7 0.085 
  
Diabetes Non-Dementia 85.5 92.1   
  
(n=247,12%) Dementia 14.5 7.9 0.115 
p-value 1 =  Pearson Chi-Square 2-sided p-value    
* significant,  if  p-value < 0.05    
 
Therefore, we considered diabetes as a confounding factor in association between 
GL and dementia because diabetes was associated with GL in both genders and with 
incident AD in men. Furthermore, Using FFQ from diabetics was not appropriate to 
measure usual dietary carbohydrate intake because diabetic patients changed their diet to 
treat the disease. Thus, 464 diabetics from the valid FFQ (n=3,634) were excluded and 
remained 3,170. After exclusion of diabetes, Table 14 shows the significant positive 
association (p=0.014) between GL and dementia in men, not for women (p=0.087).  
Cox proportional hazards regression models were used to explore the relation of 
GL with pure incident AD. Overall, 273 (8.6%) participants among 3,170 participants 
experienced development of incident dementia; AD developed in 180 (5.7% of sample 
population, 65.9% of total dementia) of these people during about 10 years observation. 
In Model I, energy adjusted GL categorized as dichotomy: upper 80% higher GL 
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group vs. 20% lowest GL group using the first quintile group as a reference was not 
associated with incident AD in men (HR for AD =1.33; 95% CI: 0.63, 2.81; p = 0.456) 
while inversely associated with incident AD in women (HR for AD = 0.62; 95% CI: 0.4, 
0.95; p = 0.027) (Table 15).  
 
Table 14. Dementia dstribution cmparison across gnder  
by eergy adjusted GL qintile 1 vs. quintile 2 - 5  
after eclusion of diabetes (n=464)  
 
 
Gender  GL Quintile 1 vs. GL Quintile 2 - 5   
 Dementia Q1 Q2 - Q5 p-value1 
Male Count 279 1068   
(n=1348) No Dementia (%) 95.7 91.3   
  Dementia (%)* 4.3 8.7 0.014 
       
Female Count 305 1518   
(n=1823) No Dementia (%) 88.2 91.3   
  Dementia (%) 11.8 8.7 0.087 
p-value 1 =  Pearson Chi-Square 2-sided p-value   
* significant, if p-value < 0.05    
 
 
Table 15. Cox proportional hazard models for AD by GL 
      
GL Q2-5 vs. Q1   
Model At Risk, n AD (%) HR (95% CI) p value 
I1   1 (reference)   
Male 1346 58 (4.3) 1.33 (0.63-2.81) 0.456 
Female 1820 122 (6.7) 0.62 (0.40-0.95) 0.027 
II2   1 (reference)   
Male 1245 56 (4.2) 1.10 (0.5-2.39) 0.817 
Female 1632 106 (5.8) 0.54(0.34-0.85) 0.007 
1
 is unadjusted raw model      
2
 is adjusted for education, MI, stroke, BMI, physical activity, smoking, 
 alcohol use, APOE ε-4 alleles, and multi-vitamins use 
GL = Glycemic Load; HR = Hazard ratio; CI = Confidence interval  
AD = Alzheimer's disease   
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Survival function graphs from SPSS survival analysis show comparisons of survival 
curves (incident AD curve) and hazard curves between low GL group (pattern 1, blue 
line) and high GL group (pattern 2, green line) in Figure 5. In the survival curve, incident 
AD appeared earlier in the higher GL intake group compared to the low GL intake group 
in men but p-value was not significant while low GL intake group had earlier AD age-
onset compared to the higher GL intake group in women with significant p-value. The 
results were unchanged after addition of all non-nutrient covariates in Model II (Table 
15). 
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Figure 5. Survival & hazard curve (incident AD) comparison by gender (Model I) 
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Mean intake of total kcal and macro-nutrients such as carbohydrates, fat, protein, 
sugar, fiber, and saturated fat were compared by GL quintiles to examine a possibility of 
confounding factors by nutritional factors in Table 16 and 17. The result was that the first 
quintile group consumed the highest total kcal, protein, fat, SFA intake in women and the 
highest protein, fat, SFA intake in men. 
The analysis of distribution of smoking and alcohol use by GL quintiles to explore 
the characteristics of the first quintile of GL intake showed that the number of current 
smokers and alcohol users were the highest percentage in GL quintile 1 in men and in GL 
quintile 1 and 2 in women in Table 18 - 21. 
 
Tabel 16. Mean intake of kcal & macro-nutrients (gram) by GL quintiles in men 
GL Q/ 1000 kcals Kcal Protein Carb Fiber Sugar Fat SFA 
1 2107 102 229 17 115 88 31 
2 2066 92 256 18 131 79 27 
3 2135 90 282 20 143 77 27 
4 2052 80 288 19 147 71 24 
5 1922 69 301 19 162 56 19 
Total mean 2060 87 270 19 138 75 26 
GL=Glycemic Load, Carb=Carbohydrates, SFA=Saturated fatty acid, Trans FA=Trans fatty 
acid 
        
        
Table 17. Mean intake of kcal & macro-nutrients (gram) by GL quintiles in women 
GL Q/ 1000 kcals Kcal Protein Carb Fiber Sugar Fat SFA 
1 1983 102 222 18 109 80 28 
2 1922 89 245 19 124 70 24 
3 1934 85 260 20 133 67 23 
4 1846 77 266 20 136 59 20 
5 1758 64 279 20 147 50 17 
Total mean 1882 82 256 19 131 64 22 
GL=Glycemic Load, Carb=Carbohydrates, SFA=Saturated fatty acid, Trans FA=Trans fatty 
acid 
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Table 18. Smoking distribution by GL quintiles in men (n=1334) 
    GL per 1000 kcals Quintiles 
    1 2 3 4 5 
Smoking Never 
143 
(17%) 
184 
(21%) 
185 
(21%) 
182 
(21%) 
167 
(19%) 
  Former 
107 
(25%) 
100 
(23%) 80 (19%) 69 (16%) 71 (17%) 
  Current 27 (59%) 12 (26%) 3 (7%) 2 (4%) 2 (4%) 
Chi2 test p-value, p<0.0000, Count (% within Ever/never smoker) 
       
       
Table 19. Alcohol use distribution by GL quintiles in men (n=1337) 
    GL per 1000 kcals Quintiles 
   1 2 3 4 5 
Alcohol use Never 
164 
(17%) 
205 
(21%) 
195 
(20%) 
209 
(22%) 
198 
(20%) 
  Former 61 (23%) 66 (24%) 60 (22%) 41 (15%) 43 (16%) 
  Current 53 (56%) 24 (25%) 13 (14%) 4 (4%) 1 (1%) 
Chi2 test p-value, p<0.0000, Count (% within Ever/never drinker) 
       
       
Table 20. Smoking distribution by GL quintiles in women (n=1814) 
    GL per 1000 kcals Quintiles 
   1 2 3 4 5 
Smoking  Never 
273 
(16%) 
321 
(19%) 
348 
(21%) 
361 
(21%) 
393 
(23%) 
  Former 24 (26%) 20 (22%) 18 (20%) 19 (21%) 11 (12%) 
  Current 7 (27%) 10 (38%) 5 (19%) 4 (15%) 0 
Chi2 test p-value, p<0.0030, Count (% within Ever/never smoker) 
       
       
Table 21. Alcohol use distribution by GL quintiles in women (n=1819) 
    GL per 1000 kcals Quintiles 
   1 2 3 4 5 
Alcohol use Never 
269 
(16%) 
320 
(19%) 
344 
(20%) 
362 
(21%) 
394 
(23%) 
  Former 21 (24%) 17 (20%) 17 (20%) 21 (24%) 10 (12%) 
  Current 14 (32%) 14 (32%) 12 (27%) 2 (5%) 2 (5%) 
Chi2 test p-value, p<0.0000, Count (% within Ever/never drinker) 
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Mean servings of food groups among GL quintile groups were revealed that the 
first GL quintile group consumed higher intake in dairy foods, eggs, meats, fish, and 
alcohol and lower intake fruits and soft drink in Table 22 (men) and 23 (women). 
Vegetable intake was not associated with the low GL intake. 
From Cox hazard regression analysis to detect a possible confounding among 
nutritional factors, the associations appeared in total kcal quartile 4 in women and in total 
SFA quartile 2 in women. After adjustment of those two nutritional factors and added 
interaction term between GL and total kcal or SFA separately in Cox hazard regression 
models (dependant variable: incident AD, independent variable: GL, adjusted covariate: 
total kcal and SFA plus their interaction term). The result from model-adjusted SFA 
showed the same result (no association in men and negative association in women) with 
the crude model indicating no confounding while the model-adjusted total kcal showed a 
different result (no association in both men and women) from the crude model indicating 
a possible confounder. After adjustment of all other demographic covariates plus 
controlling total kcal, no association between GL and incident AD became apparent in 
women in Table 24. 
 
Table 22. Mean servings of food groups by GL quintiles in men 
  GL Quintiles   
Food Groups 1 2 3 4 5 p-value 
Dairy 2.4 2.4 2.4 2.2 1.9 0.0030 
Fruits 1.9 2.3 2.6 2.6 3.1 0.0000 
Vegetables 3.4 3.3 3.6 3.2 3.1 0.0733 
Eggs 0.6 0.4 0.3 0.2 0.2 0.0000 
Meat 1.4 1.2 1 0.8 0.7 0.0000 
Fish 0.3 0.2 0.2 0.2 0.2 0.0000 
Soft Drink 0.4 0.6 0.6 0.8 1.2 0.0000 
Alcohol 0.4 0.2 0.1 0 0 0.0000 
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Table 23. Mean servings of food groups by GL quintiles in women 
  GL Quintiles   
Food Groups 1 2 3 4 5 p-value 
Dairy 2.3 2.4 2.3 2.1 1.7 0.0000 
Fruits 2.2 2.5 2.8 3 3.3 0.0000 
Vegetables 4.1 3.9 3.9 3.7 3.6 0.1072 
Eggs 0.3 0.2 0.2 0.2 0.1 0.0000 
Meat 1.4 1.1 1 0.8 0.6 0.0000 
Fish 0.3 0.2 0.2 0.2 0.2 0.0000 
Soft Drink 0.3 0.4 0.5 0.6 0.9 0.0000 
Alcohol 0.5 0.4 0.3 0.3 0.3 0.0000 
 
 
Table 24. Cox proportional hazard models for AD by GL after controlling 
total kcal  
      
GL Q2-5 vs. Q1   
 
Model At Risk, n AD (%) HR (95% CI) p value 
 
I1   1 (reference)    
Male 1346 58 (4.3) 0.967(0.28-3.40) 0.958 
 
Female 1820 122 (6.7) 0.507 (0.25-1.01) 0.053 
 
II2   1 (reference)    
Male 1245 56 (4.2) 2.899 (0.37-22.59) 0.31 
 
Female 1632 106 (5.8) 0.703(0.26-1.92) 0.49 
 
1
 is raw model adjusted for total kcal + interaction with GL    
2
 is adjusted for education, MI, stroke, BMI, physical activity, smoking, 
 
 alcohol use, APOE ε-4 alleles, multi-vitamins use, and total kcal + interaction with GL 
GL = Glycemic Load; HR = Hazard ratio; CI = Confidence interval  
 
AD = Alzheimer's disease   
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DISCUSSION 
 
 
This study found that dietary energy-adjusted glycemic load (GL) was not 
associated with the risk of Alzheimer’s disease when GL was categorized as dichotomy in 
which the first quintile (20%) was compared with combined upper level of quintiles 
(80%) and was used as the reference and total kcal was controlled as a confounder in 
elderly 65 years and older who lived or have lived in the Cache County, Northern Utah. 
These results included adjustment of covariates including education, MI, stroke, BMI, 
physical activity, smoking, alcohol use, APOE ε-4 alleles, and multi-vitamins use.  
The reason for categorizing GL into two groups (Q1 vs. Q2-5) was that the 
percentage of dementia in non-diabetic men jumped from 4.4 % in Q1 to 7.8 % in Q2. It 
was almost twice and then the rate kept constant ranging from 7.8 to 9.2 % throughout 
Q5. Furthermore, after quintiles were transformed into this dichotomy, the association 
between dementia and GL in non-diabetic men became significant. Thus we expected that 
there might be a possible association between GL and AD in men. It was also thought 
possible to link the previous finding by Charoonruk in our Cache County Study: diabetes 
had 4 times greater risk for developing AD among men than non-diabetics (62).  
The sample population of this study was started from people without diabetes and 
examined the effect of GL by comparing low GL group with high GL group related to AD. 
The reason of exclusion of diabetes from the sample population was that we wanted to 
estimate usual carbohydrate intake pattern in terms of glycemic index (GI) and glycemic 
load (GL), not affected or modified by other factors such as diabetes among baseline 
participants. The dietary treatment for diabetes affected the amount of carbohydrates 
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intake in both quality and quantity to control blood sugar, thus it consequently affected 
GL intake thereby confounded our dietary assessment.  
If the association between high GL and the risk of dementia in men we found in the 
descriptive analysis appeared in Cox proportional hazard regression models in survival 
analysis, it would be possible to relate the former finding between diabetes and incident 
AD in men to the dietary characteristic of GL. However, our finding was no association 
in both men and women. 
A negative association between GL and incident AD was appeared in women 
before we controlled total kcal as a confounder. We did not consider total kcal and other 
macro-nutrients in the previous two models as covariates. We examined total kcal and 
macro-nutrients to find why negative the finding was in women with very significant p-
value and what characteristics of the lowest quintile in women have. We found suspicious 
characteristics of the first quintile of GL in women by mean distribution of macro 
nutrients across quintiles. Noticeable thing was that the lowest quintile group consumed 
the highest amount of kcal, protein, fat, and saturated fat. Men also had a similar pattern 
(second high in kcal intake and the highest intake in protein and fat), but women showed 
a prominent trend; total kcal, protein, and fat intake decrease with increasing GL whereas 
carbohydrates, sugar, and fiber intake increase with GL. Women in Q1 group consumed 
225 more kcals, 38g more proteins, and 30g more fat per day compared to the Q5 mean 
intake. Table 17 summarized these characteristics. 
After examination of possible confounding factors among total kcal and macro-
nutrients, total kcal intake appeared as a possible confounder. As Cox hazard regression 
model was controlled with total kcal and added interaction term with GL, no association 
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was appeared in women. The significant level was closed to 0.05 and the confidence 
interval included 1.0, thus there might be other confounding factors between GL and 
incident AD. However, as the model adjusted for all other covariates including total kcal 
plus interaction with GL, the result remained the same (no association in both men and 
women) but the p-value became much greater in women thus underscoring the finding of 
association. 
Another thing to point out is dietary intake patterns of smoking and alcohol users. 
Both smokers and alcohols user had the exact same pattern: never users had higher GL 
intake, former users were middle, and current users had the lowest GL intake. Alcohol 
contains no glucose and a minimal amount of carbohydrates, so GI = 0, at the same time, 
GL = 0 because of zero GI value. Alcohol has 7 kcal per g and it is greater than 
carbohydrates (4 kcals/ g) but has zero GL value.  Thus alcohol intake might partly 
contribute to increase total kcal but decrease overall dietary GL intake. The life style of 
alcohol users may also include smoking. Both habits tend to have an association with 
dietary habits too. In other words, alcohols users tend to be more likely to smoke 
compared with non-alcohol users and tend to have unhealthy diets such as eating less 
fruits and vegetables. 
Table 18– 23 may explain these complicated characteristics of the low GL quintile 
group of people. The percentage of smoking and alcohol use was higher in the low GL 
group and it was appeared clear in men due to more people in smoking and alcohol use 
compared to women. In the mean serving intake of food groups, the low GL quintile 
group consumed more dairy foods, eggs, meats, fish, and alcohol and less fruits and soft 
drink. Vegetable intake was not associated with GL and appeared a similar number of 
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servings throughout the quintiles. 
To summarize, the low GL group had unique characteristics in life style factors, 
macro-nutrients intake, and pattern of food use: higher percentage of smoking and 
alcohol user in life style factors, high kcal, protein, fat, and saturated fat intake in macro-
nutrients intake, and more specifically higher dairy, meat, eggs, alcohol intake and lower 
fruits intake in the pattern of food use indicating that they more likely had unhealthy life 
style and dietary pattern. The inverse relationship between GL and total kcal may partly 
be explained by life style factors, particularly alcohol intake may have contributed to this 
relationship because this group consisted of a large percentage of alcohol users and 
alcohol had high kcal and zero GL value. 
Last, there might be a possible reason for the no association in men. Men had a 
consistent positive relationship between GL and dementia or AD, but significant level did 
not support its association. Maybe, because of small number of sample size (n of AD = 
58 among 1347 elderly men) partly due to a large number of exclusion for valid dietary 
assessment. Thus, continued follow-up of both men and women is important. 
To conclude, intakes of most nutrients tend to be positively correlated with total 
energy intake (114), but carbohydrates intake in terms of GL was negatively correlated 
with total kcal and other macro-nutrients such as protein and fat intake. Although GL was 
adjusted for total kcal, total energy intake still affects the relation between GL and 
incident AD. The life style factors such as smoking and alcohol use and their dietary 
pattern also are associated with GL value. Therefore, GL alone may be of limited value to 
examine the relationship between carbohydrates intake and AD. The pattern of food use 
among carbohydrates containing foods may better reveal carbohydrates-intake related to 
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incident AD. 
Further research on total kcal intake related to incident dementia or AD among 
people with or without APOE ε-4 alleles genotypes should be examined. Based on 
previous finding in Cache County Study, that fruits, vegetables, and fish intake were 
associated with reduced risk of cognitive decline, whole grain intake among total 
carbohydrates intake related to incident dementia or AD is suggested as an important 
topic for further exploration.  
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BASELINE FOOD FREQUENCY QUESTIONNAIRE 
CACHE COUNTY STUDY ON MEMORY, HEALTH, AND AGING 
UTAH STATE UNIVERSITY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CACHE COUNTY STUDY ON MEMORY IN AGING 
NUTRITION QUESTIONNAIRE 
Conducted by:  Utah State University 
Marking Instructions 
 
Please follow these few simple rules in completing this questionnaire. 
 
1. Use only a pencil.  (Please DO NOT use a pen) 
2. Darken completely the circle of the answer you choose 
3. Erase cleanly any answer that you wish to change 
4. Make no stray marks of any kind on the form 
5. For food that you never or rarely eat, please mark the first column labeled “None or  
 Less than once a month.  Please do not leave any food items blank. 
6. Please note the correct way to mark the answers. 
     
 Correct Mark Incorrect Mark   
 ? ? ? ? ? ? ? ?   
     
Please answer the following.  Check the appropriate gender, and fill in your height, weight, and age 
     
Male_____ Female_____  
     
Height_____ Weight_____ Age_____ 
     
THANK YOU!!!!    
 
DIETARY SUPPLEMENTS 
 
PLEASE INDICATE WHICH, IF ANY, OF THE FOLLOWING SUPPLEMENTS YOU ARE 
CURRENTLY TAKING.  PLEASE ANSWER “YES” OR “NO” FOR ANY SUPPLEMENT 
LISTED. 
 
1. 
 
 
Do you regularly take multivitamins 
? NO> PLEASE GO TO QUESTION 2 
?YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What specific brand do you use?__________________________ 
Excluding multivitamins, do you take any of the following supplements listed below? 
2. 
 
 
Do you regularly take Vitamin A? 
? NO> PLEASE GO TO QUESTION 3 
? YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? less than 8,000 IU ?  22,001 IU or more 
  ?8,001 to 13,000 IU ? Don’t know 
  ? 13,001 to 22,000 IU 
3. 
 
 
Do you regularly take Vitamin C? 
? NO> PLEASE GO TO QUESTION 4 
?YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? less than 400 mg ?  1301 mg or more 
  ? 401 to 700 mg ? Don’t know 
  ? 701 to 1300 mg 
4. 
 
 
Do you regularly take Vitamin C? 
? NO> PLEASE GO TO QUESTION 5 
? YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? less than 100IU ?  504 IU or more 
  ? 101 to 300 IU ? Don’t know 
  ? 301 to 500 IU 
 
5. 
 
 
Do you regularly take Calcium? 
? NO> PLEASE GO TO QUESTION 6 
? YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? less than 400 mg ?  1301 mg or more 
  ? 401 to 900 mg ? Don’t know 
  ? 901 to 1300 mg 
6. 
 
Do you regularly take Vitamin D? 
? NO> PLEASE GO TO QUESTION 7 
? YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? less than 200 IU ?  1,000 IU or more 
  ? 201 to 400 IU ? Don’t know 
  ? 401 to 1,000 IU 
7. 
 
 
Do you regularly take Vitamin B6? 
? NO> PLEASE GO TO QUESTION 8 
? YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? less than 10 mg ?  80 mg or more 
  ? 10 to 39 mg  ? Don’t know 
  ? 40 to 79 mg 
8. 
 
 
Do you regularly take Selenium? 
? NO> PLEASE GO TO QUESTION 9 
? YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? less than 80 mcg ?  251 mcg or more 
  ? 81 to 130 mcg ? Don’t know 
  ? 131 to 250 mcg 
 
FOR OFFICE USE ONLY 
(A)          (B)          (C)          
1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
  
9. 
 
 
Do you regularly take Iron? 
?NO> PLEASE GO TO QUESTION 10 
?YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? 50 mg or less  ?  401 mg or more 
  ? 51 to 200 mg  ? Don’t know 
  ? 201 to 400 mg 
10. 
 
 
Do you regularly take Zinc? 
? NO> PLEASE GO TO NEXT SECTION 
?YES> CONTINUE: 
 (A) How many years have you taken multivitamins? 
  ? 0-1 years  ? 5-9 years 
  ? 2-4 years  ? 10 or more years 
 (B) What dose do you take per day? 
  ? less than 25 mg ?  101 mg or more 
  ? 26 to 75 mg  ? Don’t know 
  ? 76 to 100 mg 
 
 
11.  DO YOU TAKE ANY OF THE FOLLOWING OTHER SUPPLEMENTS: 
Cod liver oil ...........? Yes ...........? No Folic acid............... ? Yes ...........? No 
Other fish oil ..........? Yes ...........? No Iodine .................... ? Yes ...........? No 
Niacin.....................? Yes ...........? No Brewer’s Yeast ...... ? Yes ...........? No 
Beta-caroten ...........? Yes ...........? No Magnesium............ ? Yes ...........? No 
Thiamine (vitamin B1).....? Yes .... ? No Any others? ........... ? Yes ...........? No 
B-complex vitamins .........? Yes .... ? No If yes, please specify_____________________ 
 ______________________________________ 
 
 
FOODS YOU EAT 
 
AVERAGE USE FOR PAST 12 MONTHS 
For each food listed, please mark a 
circle for how often during the past 
year, on average, you have eaten the 
serving size specified.  Be sure to mark 
a circle for every food listed.  If you 
never eat the food listed mark the 
circle in the first column. 
 
DAIRY FOODS 
NONE 
OR  
LESS  
THAN 
1  
PER  
MO. 
1-3 
PER 
MO. 
1 PER 
WK. 
2-4 
PER 
WK. 
5-6 
PER 
WK. 
1 
PER 
DAY 
2-3 
PER 
DAY 
4-5 
PER 
DAY 
6  
PER 
DAY 
Skim or low fat milk (8 oz. glass) ? ? ? ? ? ? ? ? ? 
Whole milk (8 oz. glass) ? ? ? ? ? ? ? ? ? 
Chocolate milk or cocoa (8 oz. glass) ? ? ? ? ? ? ? ? ? 
Cream or half-and-half, e.g. coffee, 
whipped (Tbs) 
? ? ? ? ? ? ? ? ? 
Sour cream (Tbs) ? ? ? ? ? ? ? ? ? 
Non-dairy coffee whitener (tsp) ? ? ? ? ? ? ? ? ? 
Sherbet, ice milk, or frozen yogurt (1/2 
cup) 
? ? ? ? ? ? ? ? ? 
Ice cream (1/2 cup) ? ? ? ? ? ? ? ? ? 
Yogurt (1 cup) ? ? ? ? ? ? ? ? ? 
Cottage or ricotta cheese (1/2 cup) ? ? ? ? ? ? ? ? ? 
Cream cheese (1 oz.) ? ? ? ? ? ? ? ? ? 
Other cheese, e.g. American, cheddar, 
etc., plain or as part of a dish (1 slice or 1 
oz. serving) 
? ? ? ? ? ? ? ? ? 
Margarine (1 tsp, added to food or bread; 
exclude use in cooking 
? ? ? ? ? ? ? ? ? 
Butter (1 tsp), added to food or bread; 
exclude use in cooking. 
? ? ? ? ? ? ? ? ? 
FRUITS ? ? ? ? ? ? ? ? ? 
Raisins (1 oz. or small pack ) or grapes 
(1/2 c) 
? ? ? ? ? ? ? ? ? 
Prunes (7 prunes or ½ cup) ? ? ? ? ? ? ? ? ? 
Bananas (1) ? ? ? ? ? ? ? ? ? 
Cantaloupe (1/4 melon) ? ? ? ? ? ? ? ? ? 
Avocado (1/2 fruit or ½ cup) ? ? ? ? ? ? ? ? ? 
Fresh apples or pears (1) ? ? ? ? ? ? ? ? ? 
Apple juice or cider (small glass) ? ? ? ? ? ? ? ? ? 
Oranges (1) ? ? ? ? ? ? ? ? ? 
Orange Juice (small glass) ? ? ? ? ? ? ? ? ? 
Grapefruit (1/2) ? ? ? ? ? ? ? ? ? 
Grapefruit juice (small glass) ? ? ? ? ? ? ? ? ? 
Other fruit juices (small glass) ? ? ? ? ? ? ? ? ? 
Strawberries, fresh, frozen or canned (1/2 
cup) 
? ? ? ? ? ? ? ? ? 
Blueberries, fresh, frozen or canned (1/2 
cup) 
? ? ? ? ? ? ? ? ? 
Peaches, apricots or plums (1 fresh, or ½ 
cup canned) 
? ? ? ? ? ? ? ? ? 
VEGETABLES ? ? ? ? ? ? ? ? ? 
Tomatoes (1) ? ? ? ? ? ? ? ? ? 
Tomato juice, V8 (small glass) ? ? ? ? ? ? ? ? ? 
Tomato sauce (1/2 cup) e.g. spaghetti 
sauce 
? ? ? ? ? ? ? ? ? 
Salsa or red chili sauce (1 Tbs) ? ? ? ? ? ? ? ? ? 
Tofu or soybeans (3-4 oz.) ? ? ? ? ? ? ? ? ? 
String (green) beans (1/2 cup) ? ? ? ? ? ? ? ? ? 
Broccoli (1/2 cup) ? ? ? ? ? ? ? ? ? 
Cabbage or cole slaw (1/2 cup) ? ? ? ? ? ? ? ? ? 
Cauliflower (1/2 cup) ? ? ? ? ? ? ? ? ? 
Brussels sprouts (1/2 cup) ? ? ? ? ? ? ? ? ? 
Carrots, raw (1/2 carrot or 4 sticks) ? ? ? ? ? ? ? ? ? 
Carrots, cooked (1/2 cup) or carrot juice 
(2-3 oz.) 
? ? ? ? ? ? ? ? ? 
Red Beets—not greens (1/2 cup) ? ? ? ? ? ? ? ? ? 
Corn (1 ear or ½ cup frozen or canned) ? ? ? ? ? ? ? ?  
Peas or lima beans (1/2 cup fresh, frozen, 
or canned) 
? ? ? ? ? ? ? ? ? 
Mixed vegetables (1/2 cup) ? ? ? ? ? ? ? ? ? 
Beans or lentils, baked or dried (1/2 cup) ? ? ? ? ? ? ? ? ? 
Dark orange (winter) squash (1/2 cup) 
(acorn, butternut squash) 
? ? ? ? ? ? ? ? ? 
Eggplant, zucchini or other summer 
squash (1/2 cup) 
? ? ? ? ? ? ? ? ? 
Yams or sweet potatoes (1/2 cup) ? ? ? ? ? ? ? ? ? 
Spinach, cooked (1/2 cup) ? ? ? ? ? ? ? ? ? 
Spinach, raw as in a salad (1 cup serving) ? ? ? ? ? ? ? ? ? 
Kale, mustard or chard greens (1/2 cup) ? ? ? ? ? ? ? ? ? 
Iceberg or head lettuce (1 cup serving) ? ? ? ? ? ? ? ? ? 
Romaine or leaf lettuce (1 cup serving) ? ? ? ? ? ? ? ? ? 
Celery (2-4 4” sticks) ? ? ? ? ? ? ? ? ? 
Sweet green or red peppers (3 slices or ¼ 
pepper) 
? ? ? ? ? ? ? ? ? 
Onions as a garnish, or in salad (1 slice) ? ? ? ? ? ? ? ? ? 
Onions as a vegetable, rings or in soup (1 
onion) 
? ? ? ? ? ? ? ? ? 
EGGS, MEATS, ETC.         ? 
Eggs (1) ? ? ? ? ? ? ? ? ? 
Chicken with skin (4-6 oz.) ? ? ? ? ? ? ? ? ? 
Chicken without the skin (4-6 oz.), 
includes grilled chicken sandwich 
? ? ? ? ? ? ? ? ? 
Turkey, including ground turkey (4-6 oz. 
or 2 turkey dogs) 
? ? ? ? ? ? ? ? ? 
Hot dogs 91) ? ? ? ? ? ? ? ? ? 
Bacon (2 slices) ? ? ? ? ? ? ? ? ? 
Processed meats, e.g. sausage, salami, 
bologna, etc. (1 piece or slice) 
? ? ? ? ? ? ? ? ? 
Hamburger (1 patty) ? ? ? ? ? ? ? ? ? 
Taco or tostado (1) ? ? ? ? ? ? ? ? ? 
Burrito (1) ? ? ? ? ? ? ? ? ? 
Enchilada (2) ? ? ? ? ? ? ? ? ? 
Beef, pork or lamb as a sandwich or 
mixed dish, e.g. stew, casserole, lasagna, 
chili etc. 
? ? ? ? ? ? ? ? ? 
Pork as a main dish, e.g. ham or chops (4-
6 oz.) 
? ? ? ? ? ? ? ? ? 
Beef or lamb as a main dish, e.g. steak, 
roast (4-6 oz) 
? ? ? ? ? ? ? ? ? 
Liver: beef, calf, or pork (4 oz) ? ? ? ? ? ? ? ? ? 
Liver: chicken or turkey (2 oz) ? ? ? ? ? ? ? ? ? 
Canned tuna fish (3-4 oz) ? ? ? ? ? ? ? ? ? 
Dark meat fish, e.g. mackerel, salmon, 
sardines, bluefish, swordfish (3-5 oz.) 
? ? ? ? ? ? ? ? ? 
Fried fish, e.g. fish sticks, fish and chips 
style fish (3-5 oz.) 
? ? ? ? ? ? ? ? ? 
Other fish (3-5 oz.) ? ? ? ? ? ? ? ? ? 
Shrimp, lobster, scallops as a main dish ? ? ? ? ? ? ? ? ? 
BREADS, CEREALS, STARCHES         ? 
Cold breakfast cereal (1 cup) ? ? ? ? ? ? ? ? ? 
Cooked oatmeal/cooked oat bran ( 1 cup) ? ? ? ? ? ? ? ? ? 
Other cooked breakfast cereal (1 cup) ? ? ? ? ? ? ? ? ? 
Instant breakfast beverage, e.g. Carnation ? ? ? ? ? ? ? ? ? 
White bread (slice), including pita bread ? ? ? ? ? ? ? ? ? 
Dark bread (slice), including pita bread ? ? ? ? ? ? ? ? ? 
English muffins, bagels, or dinner rolls (1 
each) 
? ? ? ? ? ? ? ? ? 
Muffins or biscuits (1 each) ? ? ? ? ? ? ? ? ? 
White rice (1 cup) ? ? ? ? ? ? ? ? ? 
Pasta, e.g. spaghetti, noodles, etc (1 cup) ? ? ? ? ? ? ? ? ? 
Tortillas (1-10 inch shell) ? ? ? ? ? ? ? ? ? 
Other grains, e.g. bulgur, kasha, 
couscous, etc ( 1 cup) 
? ? ? ? ? ? ? ? ? 
Pancakes or waffles (2 each) ? ? ? ? ? ? ? ? ? 
French fried potatoes (4 oz. or size of 
small fries order) 
? ? ? ? ? ? ? ? ? 
Potatoes, baked, boiled (1each), or 
mashed (1 cup) 
? ? ? ? ? ? ? ? ? 
Potato chips or corn chips (small bag or 1 
oz.) 
? ? ? ? ? ? ? ? ? 
Crackers, e.g. Triscuits, Wheat Things (5 
each) 
? ? ? ? ? ? ? ? ? 
Pizza (2 slices) ? ? ? ? ? ? ? ? ? 
BEVERAGES         ? 
Plain water, bottled or tap (1 cup or 8 oz. 
glass) 
? ? ? ? ? ? ? ? ? 
Hawaiian Punch, lemonade, or other non-
carbonated fruit drinks ( 1 glass, bottle, 
can) 
? ? ? ? ? ? ? ? ? 
Low-calorie cola, e.g. Diet Coke with 
caffeine (can) 
? ? ? ? ? ? ? ? ? 
Low-calorie caffeine-free cola (can) ? ? ? ? ? ? ? ? ? 
Other low-calorie carbonated beverage, 
e.g. Fresca, Diet 7-UP (can) 
? ? ? ? ? ? ? ? ? 
7-Up, diet ginger ale (can) ? ? ? ? ? ? ? ? ? 
Coke, Pepsi, or other cola with sugar 
(can) 
? ? ? ? ? ? ? ? ? 
Caffeine Free Coke, Pepsi, or other cola 
with sugar (can) 
? ? ? ? ? ? ? ? ? 
Other carbonated beverages with sugar, 
e.g. Sprite, Root beer (can) 
? ? ? ? ? ? ? ? ? 
Regular Beer (1 glass, bottle, or can) ? ? ? ? ? ? ? ? ? 
Light Beer (1 glass, bottle, or can) ? ? ? ? ? ? ? ? ? 
Red wine (4 oz. glass) ? ? ? ? ? ? ? ? ? 
White Wine (4 oz. glass) ? ? ? ? ? ? ? ? ? 
Liquor, e.g. whiskey, gin, etc (1 drink or 
shot) 
? ? ? ? ? ? ? ? ? 
Dark tea with caffeine (1 cup), not herbal 
tea 
? ? ? ? ? ? ? ? ? 
Green tea or herbal tea (1 cup) ? ? ? ? ? ? ? ? ? 
Coffee with caffeine (1 cup) ? ? ? ? ? ? ? ? ? 
Decaffeinated coffee (1 cup) ? ? ? ? ? ? ? ? ? 
SWEETS, BAKED BGOODS, MISC         ? 
Chocolate (bar or packet) e.g. Hershey’s 
M & M’s 
? ? ? ? ? ? ? ? ? 
Candy bars, e.g. Snicker, milky way, 
Reeses 
? ? ? ? ? ? ? ? ? 
Candy other than chocolate (1 oz) ? ? ? ? ? ? ? ? ? 
Cookies, home baked (1) ? ? ? ? ? ? ? ? ? 
Cookies, ready make (1) ? ? ? ? ? ? ? ? ? 
Brownies (1) ? ? ? ? ? ? ? ? ? 
Doughnuts (1) ? ? ? ? ? ? ? ? ? 
Cake, home baked (1 slice) ? ? ? ? ? ? ? ? ? 
Cake, ready make (1 slice) ? ? ? ? ? ? ? ? ? 
Pie, homemade ( 1 slice) ? ? ? ? ? ? ? ? ? 
Pie, ready made ( 1 slice) ? ? ? ? ? ? ? ? ? 
Sweet roll, coffee cake or other pastry, 
home baked (1 each) 
? ? ? ? ? ? ? ? ? 
Sweet roll, coffee cake or other pastry, 
ready made (1 each) 
? ? ? ? ? ? ? ? ? 
Jams, jellies, preserves, syrup, or honey 
(1 Tbs) 
? ? ? ? ? ? ? ? ? 
Peanut butter ( 1 Tbs) ? ? ? ? ? ? ? ? ? 
Popcorn (1 cup) ? ? ? ? ? ? ? ? ? 
Peanuts (small packet or 1 oz.) ? ? ? ? ? ? ? ? ? 
Other nuts (small packet or 1 oz.) ? ? ? ? ? ? ? ? ? 
Oat bran, added to food (1 Tbs) ? ? ? ? ? ? ? ? ? 
Other bran, added to food (1Tbs) ? ? ? ? ? ? ? ? ? 
Wheat germ (1 Tbs) ? ? ? ? ? ? ? ? ? 
Chowder or cream soup (1 cup) ? ? ? ? ? ? ? ? ? 
Olive oil salad dressing (1 Tbs) ? ? ? ? ? ? ? ? ? 
Other oil and vinegar dressing, e. g. 
Italian (1 Tbs) 
? ? ? ? ? ? ? ? ? 
Mayonnaise or other creamy salad 
dressing ( 1 Tbs) 
? ? ? ? ? ? ? ? ? 
Salt added at table (1 shake) ? ? ? ? ? ? ? ? ? 
Garlic (1 clove or 4 shakes) ? ? ? ? ? ? ? ? ? 
 
FOOD PREPARATION 
1. 
 
Do you eat cold breakfast cereal? 
? NO> PLEASE GO TO NEXT QUESTION 
? YES> What kind do you usually eat?______________________________________ 
2. How many teaspoons of sugar do you add to your beverages or food each day? 
 ? 0-1 ? 2-4 ? 5-9 ?10 or more 
3. When you have beef or lamb as a main dish, how is the meat cooked? 
? Rare   ? medium  ? well 
? Medium rare ? medium well ? do not eat meat 
4. How much of the visible fat on your beef, pork, or lamb do you remove before eating? 
? remove all visible fat  ? remove none 
? remove most visible fat ?do not eat meat 
? remove small part of visible fat 
5. How often do you eat food that is fried at home? (exclude Pam-type spray) 
? less than once per week  ? 4-6 times per week 
? 1-3 times per week   ? daily 
6. How often do you eat fried food away from home? (e.g. french fries, fried chicken, fried 
fish). 
? less than once per week  ? 4-6 times per week 
? 1-3 times per week   ? daily 
7. What type  and brand of cooking oil or fat do you usually use at home (e.g. corn oil, 
Mazola brand; lard) 
Type:_________________________________________________ 
Brand:________________________________________________ 
8. How does the amount of food you eat now compare to the amount you ate five years ago? 
? I eat almost the same 
? I eat less now 
? I eat more now 
9. What was the main source of your drinking water over the past year? 
? city system 
? rural or county system 
? private well 
? bottled water 
? other (please specify______________________________________________) 
 
FOR OFFICE USE ONLY 
(D)          (E)          (F)          
1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0 
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? 
 
 
 
 
 
YOUR ACTIVITES 
1. About how many hours per day do you spend in light activity, such as walking, shopping, 
child care, cooking, carrying light objects, cleaning, and repairing? 
 
Hours per day_________ 
2. About how often do you take part in moderate physical activities including bowling, golf, 
light swimming, gardening, walks over 15 minutes, fishing, light bicycling, or other light 
sports. 
?Usually every day 
? 2-6 times a week 
? About once a week 
? A few times a month 
? A few times a year 
? Rarely or never 
 
3. About how often do you take part in vigorous physical activity including jobbing, tennis, 
racquetball or squash, lap swimming, aerobics, vigorous bicycling, skiing, hiking, hunting 
or other vigorous sports… 
?Usually every day 
? 2-6 times a week 
? About once a week 
? A few times a month 
? A few times a year 
? Rarely or never 
4. How often do you talk on the telephone with family, friends, or neighbors? 
?Usually every day 
? 2-6 times a week 
? About once a week 
? A few times a month 
? A few times a year 
? Rarely or never 
5. How often do you get together with family, friends, or neighbors?  This includes meeting 
in your own home, meeting in other’s homes, or going out together. 
?Usually every day 
? 2-6 times a week 
? About once a week 
? A few times a month 
? A few times a year 
? Rarely or never 
6. How often do you attend meetings of social clubs, groups, or organizations such as bridge 
clubs, book clubs, hospital volunteer, gardening clubs, Rotary club, Kiwanis, VFW, etc. 
?Usually every day 
? 2-6 times a week 
? About once a week 
? A few times a month 
? A few times a year 
? Rarely or never 
 
Thank you for completing this questionnaire.  Please make sure that no questions or pages have 
been skipped.  Please place it in the postage-paid envelope that has been provided and seal it.  
Please return it to us in the mail.  
 
Thank you for your time and cooperation.  You have made an important contribution to our 
study of nutrition and health. 
 
Utah State University 
 
